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                                                    1.INTRODUCTION 
            The country of  Happiness is one which is free from suffering. Suffering may be 
due to internal or external factors. Without removing suffering , one cannot achieve 
happiness . Prevention , cure and contentment are the three components of medical science 
which are the means for healthy and happy living .  
          Siddha is one of  the ancient traditional system of Indian medicine. The Siddha 
system of medicine is scientifically unique art of healing. It is an integrated part of Indian 
system of medicine which is very potent. The siddha system of medicine is one among the 
foremost of all other medical system of the world. 
            The concepts of the siddha as revealed by the Siddhars is that all the living and 
non-living things are a combination of five primordial elements (Mann, Neer, Thee, Vali, 
Vin).  To regulate the living body easily, the Sidhars concised the five primordial elements 
into Mukkutrams or Humors (Vali, Azhal, Iyyam). When Mukkutram are in normal 
equilibrium, a person enjoys  the best of health. But when his equilibrium is lost, it is 
called Disease. This has been mentioned by Thiruvalluvar as, 
                              
Health status of children in a nation is highly reliable index of health of its 
population. School going children contributes around 40 % of total paediatric population 
and suffer the highest infection ratio and worm burden that attribute to poor sanitation and 
hygiene. They are vulnerable to infection and in need to be protected and educated. 
School age children have not received as much attention from the health 
providers as under five. In India, several studies have been carried out on the health status 
of school age children. These have largely been quantitative and reported morbidity 
included malnutrition (10.0 - 98.0 %) worm infestation (2.0  30.0 %) and anemia (4.0  
15.0 %) 
Worm infestation is one of the common cause of suffering by human being. 
Small children are particularly prone because they play in the mud and dirt, suck their 
fingers, eat soil, run barefoot outdoors and some times have less than ideal toilet hygiene. 
Impure water, low socio-economic state, poor sanitation coupled with low literacy rates of 
parents particularly, the mothers, are the main causes of this prevalent malady.  
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Lack of knowledge on hygiene and malnutrition in general public has 
Eventhough under five mortality has come down to 93, morbidity is on raise mainly due to 
malnutrition which is the major cause for under 5 mortality. Malnutrition under 5 under 
are mainly because of the cause worm infestation 
Medicine in the prehistoric times was intermingled with superstition, religion, 
magic and witch craft. Hygiene was given an important place in ancient Indian medicine. 
The history of herbal medicine is almost as old as human civilization.The plants are 
known to provide a rich source of botanical anthelmintics, antibacterials and insecticides 
Anthelmintic that are obtained from the natural resources may play an 
important role in the treatment of worm infestation with less side effects.Ideally an 
anthelmintic agent should have broad spectrum of action , high percentage of cure with a 
single therapeutic dose , free from toxicity to the host and should be cost effective , none 
of the synthetic drug meets the requirement. Even the most common drugs may results in 
nausea, intestinal disturbances and giddiness , resistance of the parasite to existing drug 
and their high cost warrants the search for newer anthelmintic molecules. 
The drug Elisevi kudineer  indicated for Keeri Noi, which may satisfy the drug 
need to treat the children safely and worth in fulfilling the requirements of anthelmintics . 
The clinical trial of the drug has not been done so far. So the study may help to step one 
stone up in the journey of Siddha treatment in children. 
 
 
 
 
 
                            
 
 
 
 
 
 
Aim  
and  
Objectives 
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                        2.AIM AND OBJECTIVES  
AIM:  
       To Evaluate the efficacy of  ELISEVI KUDINEER for the management of  
KEERINOI (Thread worm- Enterobius vermicularis) 
 
PRIMARY OBJECTIVE: 
To study the recurrence rate of the disease after giving the trial drug. 
 
SECONDARY OBJECTIVES: 
To review the literature of the disease Keerinoi in Siddha and Modern aspect. 
To compare the aetiology, incidence, clinical features, treatment, prognosis and 
complications of Keerinoi with Thread worm (Enterobius vermicularis) in Modern 
Science. 
To know the predominance of disease age, sex, climate, immunization history and 
socio economic status are considered. 
  To Study the Keerinoi on the basis of siddha parameters such as deranged 
mukkuttram, poripulangal, ezhu udalkattukal and envagai thervugal. 
To study the pharmacological activity, physico chemical analysis ,and chemical 
analysis of the trial drug. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Review  
            of  
      literature 
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3.REVIEW OF LITERATURE 
                                        3.a. SIDDHA ASPECT 
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the three common varieties of worms infesting the human intestines viz. 
    - Tape worm 
   -          Round worm 
   - Thread worm or maw-worm 
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According to T.V.SAMBHASIVAM PILLAI AGARATHI 
      ( )  
 Worms/Parasites of various shapes which germinates or grow in a living organism 
in the different parts of the human body. The different kinds that have their origin in 
feaces, phlegm, Blood etc. are 
   - Nematode 
   - an unknown kind 
   - Hook worm 
   - Filarial 
   - Microbe 
    - Thread worm 
   -  Red worm 
   - Worms of rectum, Oxyuris vermicularis 
    - Round worm, Ascaris lumbricoids 
   - Worms without legs for locomotion 
   - Microzoan 
   - Invisible worm 
    - Worms of blood 
    - Water worm/germs 
   - Ochromyia 
    - Flagellated worm 
   - Black coloured germ 
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   - Worms in the head 
   - an unknown kind 
   - a germ cell 
    - water worm 
    - germ responsible form kanam 
    - germ concerned in the increase or vitality 
    - worms found in the teeth, saliva etc., 
    - germ cell 
   - an unknown kind 
   - microbe of rheumatism or colic 
  - spermatozoa 
   - germs in the stomach 
    - intestinal worms such as, tapeworm etc., 
   - liver flukes 
 
According to JEEVA RATCHAMIRDHAM 
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According to BALAVAGADAM 
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According to MADHALAI NOI THOGUTHI-1 
Kirumi is of four types. They are 
 Vatha Kirumi 
 Pitha Kirumi 
 Kaba Kirumi 
 Ratha Kirumi 
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According to GURUNAADI 
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According to RATHNA SURUKKA NAADI 
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-   
-   
 Piniyari muraimai is a method of diagnosing a disease. This is based upon three 
main principles and Envagai thervugal. The three main principles are 
   - Inspection 
   - Palpation 
   - Interrogation 
Physicians-  
Poriyalarithal 
 Pori is considered as five sense organ of perception namely 
  Nose 
  Tongue 
                      Eye  
                      Skin  
                      Ear 
Pulanal arithal  
 Pulan is functions of five sense organ. They are 
  Smell 
  Taste 
  Vision 
  Sensation of taste 
  Hearing 
Vinathal (Interrogation) 
 Vinathal, asking the information of the history of the disease, clinical feature etc., 
from the patient or from his close relatives who is taking care of him 
 
20 
 
Enn vagai thervu 
 The diagnostic value of envagai thervugal is definite one in Siddha system and 
presence of vital dhoshas in the patients they are described in Siddha maruthuvangam as 
an essential one for the Siddha physician 
               
    
              
      -  
    
   
    
   
   
   
   
    
-    600 
Naadi 
Naadi in Keeri noi is given as Vatha Naadi 
    
        
    
       
    
        
    
                    
                                                                                           (  ) 
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Sparism 
 Sparism is a method of palpation by which warmth, chilness, dryness, 
roughness of skin, ulcer may be noted in Keeri Noi 
Naa 
 The method of inspection of the tongue mainly gums, teeth, lips palate etc., 
Pallor of tongue may be noted. 
 
Niram 
 Colour indicating the vatha, pitha, kaba, mukkutram, pallor, redness of the 
skin, pallor of the skin, conjunctiva, nail beds may be noted 
 
 
Mozhi 
 It includes the clarity of voice, speech, voice slurring, crying are noted 
Vizhi 
 Abnormal colour changes indicating the three doshas, pallor, excessive 
lacrimation accumulation of secretion at the angles of eyes, subconjunctival bleeding, any 
specific disease of the eyes are noted 
Malam 
                      
   -  
    
    
     
     
     
      
-   
Colour, forth, Abnormal consistency is noted 
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Moothiram 
 Quantity, colour, odour, forth, frequency, retention, deposits, presence of 
abnormal constituent such as sugar, protein etc., are noted 
    
     
     
     
     
                         
-       
 After waking up in the morning, the first voided urine is collected in a wide 
mouthed glass container and is subjected to the analysis within one and half hours. 
Neerkuri 
      
    
-     
Voided urine has the following characters 
 Niram (Colour), Edai (Specific gravity), Manam (Smell), Nurai (Frothy 
Nature), Enjal (Quantity) 
 
Neikkuri 
 The specimen collected for neikkuri is kept open in a glass dish being 
exposed well to the sunlight. Add one drop of gingili oil without shaking. It should not be 
disturbed from its position and spreading of the oil drop should be observed keenly the 
direction in which it spreads within few seconds and conclude the diagnosis as follows 
     
     
    
-       
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Mukkutram 
    
     
    
     
    
     
    
     
-   
Human body is influenced by mukkutram i.e. Vatham, Pitham and Kabam. They are 
responsible for normal physiological conditions of the body. 
Treatment 
 Treatment is based upon accurate recongestion of aetiology, diagnosis and 
prognosis of the disease the proper treatment is based on proper diagnosis particularly with 
a view to the thrithosha pathology before the treatment is given to the patient we have to 
ascertain whether the disease is curable or rarely curable or incurable. Before starting the 
actual treatment the deranged thri dhosha is noted to the normal range. 
    
   -  
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            In this disease the unhygienic habits insanitary surrounding, improperly cooked 
food, lower the resistance of the individual resulting in upsetting the function of the vatha 
the deranged vatha cases dysfunction of kukkiyanal which permits the multiplication of 
the intestinal worms in the aamasayam 
Pathiyam 
 During the course of treatment, the drug is administrated to the patients according 
to the nature of disease and the patients are advised to follow certain restrictions regarding 
diet and physical activities. This type of medical advice in Siddha system of medicine is 
termed as Pathiyam. Importance of Pathiyam is quoted as follows. 
    
       
     
    
-   
The patient with keeri noi was advised to avoid unhygienic foods. 
Diet 
     
                                                        -  
              
   
-  
      
 health. Good diet is one- 
which should not affect health by increasing or decreasing the thridhoshas. 
 In general case of children with kudal kirumi, the diet should be in easily 
digestable form and should be a nutritional one. The Saaram, Senneer which are easily 
affected can be corrected by taking Puzhungal arisi, Paal annam, Nei annam, Green leafy 
vegetables, and fruits. Nel pori and Pori urundai can be taken to avoid Nausea and various 
digestive problems and quoted in agasthiyar gunavagadam text. 
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Keerai Vagaigal 
          Greens like Karisalai, ponnanganni, arukeerai, murungai keerai having haemantinic 
property may be given daily. In worm infestation agathi keerai, paharkai,chundaivatral, 
veappilai, pudhina, poondu, venthayam, paruppu keerai are advised. 
 
Kaikarigal & Pazhavakaigal 
 Kathiri pinju, Avarai pinju, murungai pinju, vazhai kachal may be given along with 
other food stuffs 
 Paerichai, Naaval, Maadhulai, Aththi are rich sources for iron which are to be 
taken. 
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3.b.MODERN ASPECT (ENTEROBIUS VERMICULARIS) 
Intestinal parasites are worms, soft bodied organisms that can infest human and 
animals. Parasitic worms fall into several different classes and include hook worms, round 
worms, tapeworms, whipworms, and pinworms. The parasitic infestations are acquired by 
ingestion, inhalation or penetration of the skin by the infective worms. In India, favorable 
circumstances exist for high morbidity due to rapid industrialization. Due to open air 
defecation and added to it the menace of flies and other insects, poor personal cleanliness, 
habits of barefoot walking and poor disposal system of human excreta, favors worm 
infestation in children.   
Intestinal parasitic infections are amongst the most common infections worldwide. 
It is estimated that some 3.5 billion people are affected, and that 450 million are ill as a 
result of these infections, the majority being children. These infections are regarded as 
serious public health problem, as they cause iron deficiency anemia, growth retardation in 
children and other physical and mental health problems. In addition, poor sanitary and 
environmental conditions are known to be relevant in the propagation of this infectious 
agent. 
According to estimates of World Health Organization (WHO), infection with 
round worm (Ascaris Lumbricoides), whipworm (Trichuris Trichiura), Thread worm 
(Enterobius vermicularis) and hookworms (Ancylostoma duodenale and Necator 
americanus) with associated morbidity, affect approximately 250 million, 46 million and 
151 million people, respectively. About half the population in South India, and 50 percent 
of school children in tribal areas of central India, are infected with Ascaris lumbricoides, 
Enterobius vermicularis, Trichuris trichiura and/or hookworm. The overall prevalence of 
helminthes infestation in children in India is about 50 percent in urban and 68 percent in 
rural areas. Helminthic infections are more prevalent among the children. They constitute 
12 percent of total disease burden in children. 
               In children, intestinal parasitic infections, particularly soil-transmitted 
helminthiasis is a common health problem in tropical countries. Younger children are 
predisposed to heavy infections with intestinal parasites since their immune systems are 
not yet fully developed, and they also habitually play in faecally contaminated soil. In 
addition to considerable mortality and morbidity, infection with intestinal helminthes has 
been found to profoundly affect a child's mental development, growth and physical fitness 
while also predisposing children to other infections. Several factors like climatic 
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conditions, poor sanitation, unsafe drinking water, and lack of toilet facilities are the main 
contributors to the high prevalence of intestinal parasites.  
 
INTESTINAL PARASITES IN HUMAN HISTORY  
During our relatively short history on Earth, humans have acquired an amazing 
number of parasites, about 300 species of helminth worms and over 70 species of protozoa 
. (Ashford, R. W., and W. Crewe. 1998. The parasites of Homo sapiens. Liverpool School 
of Tropical Medicine, Liverpool, United Kingdom.) .We are beginning to learn a lot about 
the past history of parasitic infections from studies of archaeological artifacts, such as the 
presence of helminth eggs or protozoan cysts in coprolites (fossilized or desiccated feces) 
and naturally or artificially preserved bodies; from such studies has emerged a new 
science, palaeoparasitology. Examples of some of these discoveries will be discussed later. 
So vast is the field of human parasitology, and so many and far-reaching the discoveries 
made, that it is not possible to do justice to the whole subject. Therefore; only the most 
significant aspects and the most important parasites are considered under two major 
headings, the helminth worms and the protozoa. 
DISCOVERY OF THE HELMINTHIS WORMS                    
Because of the large size of some helminths, such as the roundworm Ascaris and 
the tapeworms, it is practically certain that our earliest ancestors must have been aware of 
these common worms. There is some evidence for this assumption based on contemporary 
studies of primitive tribes in Sarawak and North Borneo, where Hoeppli found that most 
people are aware of their intestinal roundworms and tapeworms (Hoeppli, R. 1956. The 
knowledge of parasites and parasitic infections from ancient times to the 17th century. 
Exp. Parasitol. 5:398-419.). Some historians have identified references to helminth worms 
and their diseases in the Bible, but the relevant passages are open to several 
interpretations. Among the Egyptian medical papyri, the Ebers papyrus refers to intestinal 
worms, and these records can be confirmed by the discovery of calcified helminth eggs in 
mummies dating from 1200 BC. The Greeks, particularly Hippocrates (460 to 375 BC] 
Roman physicians including Celsus (25 BC to AD 50) (Spencer, W. 1948-1953. 
Translation of A Celsus De medicina. Loeb Classical Library, Heinemann, London, 
United Kingdom.) and Galen (Galenus of Pergamon, AD 129 to 200) (Kuhn, K. (ed.). 
1821-1833. Galen (Galenus). Opera omnia, 22 vols. Leipzig, Germany.) were familiar 
with the human roundworms Ascaris lumbricoides and Enterobius vermicularis and 
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tapeworms belonging to the genus Taenia. Somewhat later, Paulus Aegineta (AD 625 to 
690) clearly described Ascaris, Enterobius, and tapeworms and gave good clinical 
descriptions of the 24  
Infections they caused (Grove, D. I. 1990. A history of human helminthology. CAB 
International, Wallingford, United Kingdom.). Following the decline of the Roman 
Empire, the study of medicine switched to Arabic physicians, including Avicenna, who 
recognized not only Ascaris, Enterobius, and tapeworms but also the guinea worm, 
Dracunculus medinensis,which had been recorded in parts of the Arab world, particularly 
around the Red Sea, for over 1,000 years. The medical literature of the Middle Ages is 
very limited, but there are many references to parasitic worms. In some cases, they were 
recognized as the possible causes of disease but in general, the writings of the period 
reflect the culture, beliefs, and ignorance of the time. The science of helminthology really 
took off in the 17th and 18th centuries following the reemergence of science and 
scholarship during the Renaissance period. Linnaeus described and named six helminth 
worms, Ascaris lumbricoides, Ascaris vermicularis (Enterobius vermicularis), Gordius 
medinensis (Dracunculus medinensis), Fasciola hepatica, Taenia solium, and Taenia lata 
(Diphyllobothrium latum) (Linnaeus, C. 1758. Systema Naturae, sive regina tria naturae 
systematice proposita por classes, ordines, genera, species cum characteribus differentiis 
synonymis, locis, 10th ed. L. Salvi, Holmiae, Sweden.). Thereafter, more species were 
described until at the beginning of the 20th century, 28 species had been recorded in 
humans, a number that has now grown to about 300 species, including accidental and very 
rare records (Coombs, I., and D. W. T. Crompton. 1991. A guide to human helminthology. 
Taylor & Francis, London, United Kingdom.). Even if some of these are doubtful, at least 
280 species are recognized by Ashford and Crewe in their annotated checklist (Ashford, R. 
W., and W. Crewe. 1998. The parasites of Homo sapiens.Liverpool School of Tropical 
Medicine, Liverpool, United Kingdom.) 
INTESTINAL NEMATODES 
The largest number of helminth organisms that parasitize humans is found in the 
roundworm group. Several roundworms are important in causing disease; some of these 
have other mammalian hosts, and some are considered to be pathogenic only under certain 
circumstances, Consquently, there is great variation in life cycle stages and pathologic 
sequelae found in humans.  
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Nematodes are unsegmented helminthes with bilateral symmetry, have a fully 
functional digestive tract, are usually long and cylindrical, and vary from a few 
millimeters to over a meter long. Their numbers per patient vary considerably; however, 
worm size and numbers do not necessarily correlate with symptoms or pathologic changes. 
All nematodes that are parasitic in humans have separate sexes, with the male 
usually being smaller than the female. Egg production varies considerably from species to 
species but tends to be comsistent within a specific group.  
The life cycle of nematodes has five successive stages; four larval stages and the 
adult. In most cases, the third-stage larva is the infective stage. The eggs and larvae of 
nematodes living in the intestinal tract are passed outside the body in the feces or may be 
deposited on the perianal skin by the female worm. Eggs of certain species are almost 
fully embryonated, while other species may require an extended period of egg 
embryonation in the soil. In some cases, the eggs are infective when swallowed and other 
eggs will hatch in the soil, thus initiating infection by larval penetration of the human skin 
rather than egg ingestion. 
Usually, the host response to the presence of these worms is directly related to the 
worm burden. Diagnosis of these infections depends on the recovery and identification of 
adult worms, eggs, or larvae. 
 World Health Organization estimates suggest that over 3.5 billion people carry 
nematode infections.With these numbers in mind, it is not uncommon for almost any 
laboratory within the United states to occasionally recover helminth eggs, larvae, or adults 
from human specimens. Unfortunately, lowering the intensity of infection  in a host 
population through the use of chemotherapy may produce minimal declines in 
transmission relative to its endemic level. 
Enterobiasis 
Synoyms 
Threadworm infection, pinworm infection, seatworm infection, oxyuriasis 
Causative Agent 
Enterobius vermicularis 
Enterobius vermicularis has been known since ancient times and has been studied 
extensively through the years; its original name was Oxyuris vermicularis . E.vermicularis 
ost common human parasitic infection .Prevalence in 
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children can be high, a fact that has been recorded despite the difficulties in confirming the 
infection. 
           Although there has been some discussion of Enterobius gregorii being a distinct 
species of pinworm, it appears that this organism may actually be a young stage of 
E.vermicularis. A series of 849 male pinworms from a single individual were examined. 
Based on spicule morphology, the worms were classified into differwnt groups, However, 
various transitional forms were observed in the spicule  morphology in the worms with 
intermediate body size between E.vermicularis and E.gregorii, showing that the basal 
portion of the spicule of E.vermicularis develops after completion of the E.gregorii-type 
basal portion. 
 
History 
            Eggs of threadworm have been found in a 10,000 year old coprolith in USA 
common parasitic infection. There is a common saying about 
has been estimated that about 200 million people in the world are infected. Leuckart in 
1865 described the complete life cycle of the worm. 
 
Geographical Distribution 
  It is cosmopolitan, found all over the world.   
 
Location in the Host 
           The adults are found in the lumen of the caecum and appendix. Sometimes they 
may also be present in the ascending colon and ileum. The anterior end of the worm 
attaches to the mucosa. 
 
Morphology 
Thread worm is a nematode with a finely striated cuticle. It can be seen with the 
naked eye as tiny bits of thread white in colour.The oral end lacks a true buccal capsule 
but has three lips with a dorso-ventral bladder-like expansion of the cuticle. 
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Male worm  
          The male measures 2-4mm in length and 0.1-0.2mm across its girth.The posterior 
end of the body is curved and sharply truncated. It possesses a sharply curved conspicuous 
terminal copulatory spicule. The gubernaculums is absent.It has a single tubular testis, two 
terminal vesicles and ejaculatory duct leading to the cloaca. Male worm is rarely seen as it 
dies immediately after fertilizing the female. 
Female worm 
             It is 8-12 mm in length and 0.3-0.5 mm across its thickest part. The posterior 
extremity is straight and drawn out into a long, tapering and finely pointed tail which is 
about 1/3rd of the length of the worm. It looks like a pin and hence, the name pinworm. 
The female reproductive organs are paired and T-Shaped. The vulva opens mid ventrally 
just in front of the middle part of the body. In a gravid worm uterus is distended with large 
number of ova (on average about 11,000 in number)  
 
Difference between male and female threadworms 
 
   Male      Female 
 
Size   Very small      Larger than male 
   (2-4 x 0.1-0.2 mm)    (8-12 x 0.3-0.5 mm) 
   Smaller than               but smaller than a  
   Female worm     hookworm 
 
Posterior end  Coiled ventrally    Tapering and straight 
 
Life Span  
          It is very short. Adult males die immediately after fertilization where as adult 
females live for 37-100 days. 
 
Eggs 
The worm is oviparous.  
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Characters of the threadworm eggs 
 Asymmetrical in shape, planoconvex 
 Not bile stained 
 Measures 50-60 µm x 30µm 
 Surrounded by a transparent shell 
 Composed of 2 layers of chitin 
 Contains a coiled tadpole like larva 
 Floats in saturated salt solution  
 Coated on outside by albumin gel which helps in adherence of egg to skin and 
clothes 
 Become infective after exposure to atmospheric oxygen for 6 hrs. 
 More resistance to antibiotics.  
Life Cycle 
           The lifecycle begins with eggs being ingested. The eggs hatch in 
the duodenum (i.e., first part of the small intestine). The emerging pinworm larvae grow 
rapidly to a size of 140 to 150 micrometers in size, and migrate through the small intestine 
towards the colon.During this migration they moult twice and become adults.Females 
survive for 5 to 13 weeks, and males about 7 weeks.The male and female pinworms mate 
in the ileum (i.e., last part of the small intestine), whereafter the male pinworms usually 
die and are passed out with stool. The gravid female pinworms settle in 
the ileum, caecum (i.e., beginning of the large intestine), appendix and ascending colon, 
where they attach themselves to the mucosa and ingest colonic contents. Almost the entire 
body of a gravid female becomes filled with eggs. The estimations of the number of eggs 
in a gravid female pinworm ranges from about 11,000 to 16,000. The egg-laying process 
begins approximately five weeks after initial ingestion of pinworm eggs by the human 
host.        
            The gravid female pinworms migrate through the colon towards the rectum at a 
rate of 12 to 14 centimeters per hour. They emerge from the anus, and while moving on 
the skin near the anus, the female pinworms deposit eggs either through (1) contracting 
and expelling the eggs, (2) dying and then disintegrating, or (3) bodily rupture due to the 
host scratching the worm. After depositing the eggs, the female becomes opaque and dies. 
The reason the female emerges from the anus is to obtain the oxygen necessary for the 
maturation of the eggs. 
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      Figure 1. Pin worm eggs                                    Figue 2 Pin worm egg 
                     
 
 
            
                          Figure: 3: Life cycle 
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            Pinworm infection spreads through human-to-human transmission, 
by ingesting (i.e., swallowing) infectious pinworm eggs. The eggs are hard and can remain 
viable (i.e., infectious) in a moist environment for up to three weeks. They do not tolerate 
heat well, but can survive in low temperatures: two-thirds of the eggs are still viable after 
 
            After the eggs have been initially deposited near the anus, they are readily 
transmitted to other surfaces through contamination. The surface of the eggs is sticky 
when laid, and the eggs are readily transmitted from their initial deposit near the anus to 
fingernails, hands, night-clothing and bed linen. From here, eggs are further transmitted to 
food, water, furniture, toys, bathroom fixtures and other objects. Household pets often 
carry the eggs in their fur, while not actually being infected. Dust containing eggs can 
become airborne and widely dispersed when dislodged from surfaces, for instance when 
shaking out bed clothes and linen. Consequently the eggs can enter the mouth and nose 
through inhalation, and be swallowed later. Although pinworms do not strictly multiply 
inside the body of their human host, some of the pinworm larvae may hatch on the 
anal mucosa, and migrate up the bowel and back into the gastrointestinal tract of the 
original host. This process is called retroinfection. According to Burkhart (2005), when 
this retroinfection occurs, it leads to a heavy parasitic load and ensures that the pinworm 
infestation continues. This statement is contradictory to a statement by Caldwelli (1982), 
who contends that retroinfection is rare and not clinically significant. Despite the limited, 
13 week lifespan of individual pinworms, autoinfection(i.e., infection from the original 
host to itself), either through the anus-to-mouth route or through retroinfection, causes the 
pinworms to inhabit the same host indefinitely.  
 
Mode of infection 
        It is primarily a disease of children and intra-familial transmission is very common. 
The different modes of transmission are: 
 
a. Direct transfer of eggs from anus to the mouth by way of contaminated fingers. 
b. Retroinfection is seen primarily in adults when eggs catch in the perianal area and 
the larvae migrate back in the bowels to mature 
c. Through contaminated night clothes, bed linen etc. where eggs can remain viable 
and infective for 2-3 weeks. 
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d. Airborne transmission is likely and spread in a family or group of children may 
occur in this way.  
 
Source of Infection 
           Infected human beings are the only source.  
 
Clinical Manifestations 
           The clinical symptoms could be due to intestinal or ectopic enterobiasis. Majority 
of the infections are essentially asymptomatic. 
 Pruritus ani is the main clinical presentation.All the clinical features which may be 
produced in enterobiasis are given 
 Ectopic enterobiasis occurs when female worms invade organs outside the normal 
habitat of intestine. This spread occurs most frequently in women because the vagina is 
w  
 
Symptoms Attributable to Intestinal Enterobiasis 
 
 Pruritis ani 
 Nocturnal enuresis 
 Perianal excoriations 
 Abdominal pain 
 Anorexia 
 Nail biting 
 Appendicitis 
 Nervousness 
 Insomnia 
 Hyperactivity 
 Loss of weight 
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Symptoms Attributable to Ectopic Enterobiasis 
 Salpingitis 
 Omentitis 
 Cervicitis 
 Peritonitis 
 Periappendicitis. 
 Recurrent UTI 
 
Pathology 
          Threadworms lack buccal apparatus suited to tissue penetration and may gain 
entrance to extra-intestinal sites by utilizing small abrasions in the gut mucosa. There may 
be haematogenous spread to different organs such as liver, Spleen and lungs. There is 
mucosal ulceration and sub-mucosal abscesses in the intestinal enterobiasis.  
 Extra intestinal lesions show eosinophilc and lymphocytic infiltration, ulceration, 
necrosis and granuloma formation 
 
Epidemiology 
      
 It is cosmopolitan in distribution. Over 200 million infected. 
 More in temperate climates, probably because of less frequent bathing and more 
frequent use of soiled underclothes 
 Rate of infection is highest in children 
 Three times more common in adult females than males. 
 More in whites than in blacks, may be due to racial immunity 
 Infection can be auto infection, retroinfection or airborne 
 More in developed countries 
 Disease found in all rich and poor, educated or uneducated 
 Eggs highly infective, can infect within 6 hrs of being laid 
 Eggs highly resistant to antiseptics 
 Infection is not transmitted from pet animals such as dogs and cats 
 Infection associated frequently with Dientamoeba fragilis infection 
 Difficult to eradicate from family because of extra-familial source of infection 
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Laboratory Diagnosis 
      Threadworm infection is suspected in children with perianal itching, insomnia and 
restlessness. Diagnosis is made by finding out the adultworms and demonstration of eggs. 
 
Detection of Adult Worms 
       Worms can be discovered by patients themselves or parents. These can also be 
recovered after an enema. Patient should be instructed to preserve the worm in alcohol of 
10 per cent solution of formaldehyde for examination in the laboratory. Typical features as 
described above can be seen under the microscope. 
 
Demonstration of Eggs 
        Stool examination for finding the eggs of threadworm is not recommended because 
the worm lays eggs on the perianal region and despite best efforts using stool 
concentration techniques also, not more than 5 per cent of the patients will show ova in the 
faeces. Ova can be recovered from patients by using any of the following methods 
  
a. Using a NIH (National Institute of Health) swab. Perianal scrapings early in the 
morning before the patient takes bath are taken and examined for threadworm 
eggs. 
b. Cellulose tape collection  The tape is folded sticky side out over the end of a slide 
or tongue blade.pressed firmly against the perianal area and then spread on a glass 
slide and examined under the low power of a microscope. The swab should be 
taken by the patient. 
 
On 3 to 5 consecutive mornings, before bathing and brought to the laboratory for 
examination.  
      About 50 percent of the infections are usually detected by single examination. 90 per 
cent by three examinations and 99 per cent by 5 consecutive examinations.      
       The ova can also be discovered from nail washing, bed linen and inanimate objects in 
Papanicolou smear taken from vagina. 
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                                         Figure: 4 Scotch Tape Test 
 
         
Prevention and control 
        a. Children should keep their finger nails short 
        b. Frequent hand washing before meals and after defecation 
        c. Good personal Hygiene 
        d. Treatment of infected case and all other members in the family or institution 
        e. Fingers should not be put in mouth, as a habit 
        f. Ordinary washing of bedding will usually kill threadworm eggs. 
 
 Total prevention is neither realistic nor possible. It is also recommended that 
children sleep in closed garments. Sun and UV lamp radiation will destroy the eggs in the 
environment. However the level of chlorination done in swimming pools may not kill the 
eggs. 
                         
 
 
 
 
                             
 
 
     
   Drug review 
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                             3.c.DRUG REVIEW 
ELISEVI KUDINEER  
INGREDIENTS:  
 Elisevi elai          (Merremia emarginata)            
 Murungaipattai   (Moringa oleifera)                        
 Kadukaaithol      (Terminalia chebula)                    
 Thaanrikaaithol   (Terminalia bellirica)                  
 Nellivatral           (Phyllanthus emblica )                
Vaaividangam       (Embelia ribes)  
 
                        - Elikkadhilai 
Scientific Classification  
 
Kingdom  : Plantae  
Division   : Angiosperms 
Order       : Solanales 
Family     : Convolvulaceae 
Genus      : Merremia 
Species    ; emarginata  
 
Synonyms: Merremia gangetica (Linn.) Cuf. Ipomoen reniformis Choisy 
 
Vernacular Name: 
                San: Akhukarni, Hin:Musakani, Musakari Mal: Eliccevi.  
              Tam:Eikkattukkirai,Perattaikkirai           Tel: Elika jimudu 
 
Parts Used: Whole plant 
 
-  -  -  
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-  
 
 
  
  
Uses:                                           
The plant is bitter, acrid, refrigerant, deobstruant, diuretic, alterant, anthelmintic, 
carminative and digestive. It is useful in nephropathy, uropathy, cardiac diseases, fever, 
anaemia, leucoderma, stangury, otalgia, cephalalgia and rat bite. 
 
Chemical components  
Amino acid, 
Tannins (condensed and pseudotanins), 
Flavonoids,  
Terpenoids, 
Cardiac glycosides 
 
Pharmacological studies 
 
Anthelmintic:  
                     Study evaluated ethanol and aqueous extracts of whole plant of Merremia 
emarginata for anthelmintic activity against Ecinia foetida and Pheretima posthuma. 
Results showed dose dependent increase in anthelmintic activity. The ethanolic extract 
showed a significant anthelmintic activity at highest concentration of 250 mg/ml. 
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Scientific Classification  
 
Kingdom  : Plantae 
Division    : Angiosperm 
Order        : Myrtales 
Family      : Combretacea 
Genus       : Terminalia 
Species     : chebula 
 
Vernacular Name:Eng: Chebulic myrobalan; Hin: Hara, Harara, Harad; Kan:Harra, 
Karakkayi, Alalekayi;  Mal:Katukka; San: Haritaki, Pathya, Abhaya; Tam:Katukkay 
Tel: Karakkaya, Karitaki 
 
-  
 
 
 
 
- - - - -
 
 
 
42 
 
 
         
-  
 
 
 
 
 
Chemical Constituents: 
            Chebulin from flowers. Palmitic, stearic, oleic, linoleic, arachidic and behenic 
acids from fruit kernels. Fruits contain about 30% of an astringent substance; astringency 
is due to the charectersitic principle chebulnic acid. Also contain tannic acid 20-40%, 
gallic acid, resin etc. and a purgative glycoside of anthraquinone derivative. Chebulin 
exhibited antispanmodic action on smooth muscle similar to papaverine. 
 
Pharmacological studies 
1.Anti anthelmintic 
 
Uses:  
          The fruits are astringent, sweet, acrid, bitter, sour, thermogenic, anodyne, 
anthelmintic, anti-inflammatory, vulnerary, alterant, stomachic, laxative, purgative, 
carminative, digestive, cardiotonic, aphrodisiac, antiseptic, diuretic, febrifuge, depurative 
and tonic. They are useful in vitiated conditions of tridosa, wounds ulcers, inflammations, 
gastropathy, anorexia, helminthiasis, flatulence, haemorrhoids, jaundice, hepatopathy, 
splenopathy, pharyngodynia, hiccough, cough, urophathy, versical and renal calculi, 
cephalalgia, epilepsy, ophthalmopathy, skin diseases, leprosy, intermittent fever, cardiac 
disorders, stomatitis, neuropathy and general debility. 
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                                    - Nelli Vatral 
 
Scientific Classification  
Kingdom     : Plantae 
Division      : Angiospem 
Order          : Malpighiales  
Family        : Euphorbiaceae 
Genus         : Phyllanthus 
Species        : embelica 
 
Synonyms: Emblica officinalis Gaertn. 
 
Vernacular Name:  
           San: Amalaki, Dhatri  Eng: Emblic myrobalan, Indian gooseberry Hin:Amlika 
amalak, amvala; Kan:Nellka Mal:Nellimaram, Nellikka Tam: Nelli; Tel:Usirikaya, 
Amalakamu 
 
Parts Used: Root bark, bark, leaves, fruits 
 
- 
 
 
-  
 
- - -  
- 
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-  
 
 
 
 
Chemical Constituents:  
         The major amino acids present are; alanine, aspartic acid, glutamic acid, lysine, and 
proline, analysis of fresh fruit pulp gave moisture, protein, fat carbohydrates fibre, 
minerals, iron, niacin, and vitamin fruit ash contains; chromium and copper.  
Uses:  
          The root bark is astringent and is useful in ulcerative stomatitis and gastrohelcosis. 
The bark is useful in gonorrhea, jaundice, diarrhea and myalgia. The leaves are useful in 
conjunctivitis, inflammation, dyspepsia, diarrhea and dysentery. The fruits are sour, 
astringent, bitter, acrid, sweet, coling, anodyne, ophthalmic, carminative, digestive, 
stomachic, laxative, alterant, alexeteric, aphrodisiac, diuretic, antipyretic, tonic and 
trichogenous. They are useful in vitiated conditions of tridosa; diabetes, cough , asthma, 
bronchitis, cephalalgia, phthalmopathy, dyspepsia, colic, flatulence, hyperacidity, peptic 
ulcer, erysipelas, skin diseases, leprosy, haematemesis, inflammations, anaemia, 
emaciation, hepatopathy, jaundice, strangury, diarrhea, dysentery, 
haemorrhages,leucorrhoea, menorrhagia, cardiac disorders, intermittent fevers and 
greyness of hair.  
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                                  - Thantri 
Scientific Classification  
Kingdom  : Plantae 
Division   : Angiosperm 
Order       : Myrtales 
Family     :Combretaceae  
Genus      : Terminalia 
Species    : bellirica 
Vernacular Name:  
       Eng: Belliric myrobalan; Hin:Bahenda, Bahaira; Kan:Behara, Tanrikayi, Santikayi; 
Mal:Tani,Tannikka; San: Vibhirakah,Aksah; Tam: Tanni, Banrikkai; Tel: Tandra, Tani 
- 
 
 
-  
- - -  
- 
 
 
 
 
- 
 
-  
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Chemical Constituents:  
                  Fruits -sitosterol, gallic acid, ellagic acid, ethyl 
galate, galloyl glucose and chebulagic acid. Heartwood and bark contain ellagic acid and 
the seed-coat of the fruit contains gallic acid. Kernel oil had a purgative action, and fruit 
extract produced fall in blood pressure and significant increase of bile secretion in 
experimental animals. 
Uses:  
           . The fruits are anthelmintic, astringent, acrid, sweet, thermogenic, anti-
inflammatory, anodyne, styptic, narcotic, digestive,  aperients, experctorant, ophthalmic, 
antipyretic, antiemetic and rejuvenating. They are useful in vitiated conditions of kapha 
and vata, cough, bronchitis, pharyngitis, insomnia, dropsy, dyspepsia, flatulence, 
vomiting, haemorrhages, opthalmopathy, strangury, splenomegaly, cephalalgia, skin 
diseases, leprosy, fevers, ulcers and general debility. The mature and dry fruit is 
constipating and is useful in diarrhea and dysentery. The oil obtained from the seeds is 
trichogenous and is useful in dyspepsia, skin diseases, leucoderma and gryness of hair. 
The bark is mildly diuretic and useful in anaemia and leucodes 
Pharmacological studies 
Analgesic activity 
            The antisecretory and analgesic activities of the crude extract of Terminalia 
bellerica. T. bellerica extract at the dose range of 300 - 1000 mg/kg inhibited the castor 
oil-induced intestinal fluid secretion in mice.The extract also dose-dependently (50 - 100 
mg/kg) where it reduced the numbers of acetic acid mediated in mice. These results 
indicate that TB exhibit antisecretory and anti-nociceptive effects,hence justifying its 
medicinal use in diarrhea and pain. 
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                          - Murungai 
Scientific Classification  
 
Kingdom  : Plantae  
Division   : Angiosperm 
Order       : Brassicales 
Family     : Moringaceae 
Genus      : Moringa 
Species    : oleifera 
 
Synonyms: Moringa pterygosperma Gaertn. 
Vernacular Name:  
        San: Sigruh, sobhanjanah  Eng: Horse-radish tree, Drumstick tree Hin:Sahijan, 
Mungana  Kan: Nuggi, Murunga  Mal:Murinna   Tam:Murunkai  Tel: Munaga, Mulaga 
- 
 
-  
- -  
-  
- 
 
 
 
 
- 
 
-  
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Chemical Consistuents:  
             Carotene, nicotinic acid and ascorbic acid oxidase sulphur, and a prolamin. 
The essential amino acids present in the total proteins are arginin, histidine, lysine, 
tryptophan, phenylalanine, methionine, thereonine, leucine, isoleucine, and valine, No-
protein nitrogen histidine, arginine, threonine, valine, methionine, phenylalanine, 
isoleucine, leucine, and tyrosine, lysine, and tryptophan traces and cystine nil. The 
essential amino acids present in the leaf proteins are arginine histidine lysine 
tryptophan, phenylalanine, methionine, threonine, leucine, isoleucine, and valine. 
zeatin, quercetin, beta-sitosterol, and kaempferol.  
 
Pharmacological Studies: 
Antihelmintic  
 
Uses:  
            The roots are bitter, acrid thermogenic, anthelmintic, digestive, carminative, 
constipating, anodyne, anti-inflammatory, emmenagogue, sudorific diuretic, ophthalmic, 
rubefacient, expectorant, haematinic, antilithic, alexipharmic stimulant and vesicant. They 
are useful in vitiated conditions of Vata and Kapha, dyspepsia, anorexia, verminosis, 
diarrhea, colic flatulence, otalgia, paralysis,inflammations, Fever, vesical and renal calculi, 
ascites, ophthalmopathy, cough, asthma bronchitis, pectoral diseases, splenomegaly, 
epilepsy, hysteria, cardiopathy, abscess and pharyngodynia. The bark is acrid, bitter, 
thermogenic, abortifacient, antifungal and cardiac and circulatory stimulant. It is useful in 
ascites, vitiated conditions of vata and kapha and ringworm. The leaves are anti-
inflammatory, anodyne, anthelmintic, ophthalmic and rich in vitamins A and C. They are 
useful in scurvy, vitiated conditions of kapha and vata, wounds tumours, inflammations 
and helminthasis. The seeds are acrid, bitter, anodyne, anti-inflammatory, purgative, 
antipyretic and ophthalmic. They are useful in neuralgia, inflammations, intermittent 
fevers and ophthalmopathy. 
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 -Vaivilangam 
Scientific Classification  
 
Kingdom  : plantae 
Division    : Angiosperms 
Order        : Ericales 
Family      : Myrsinaceae    
Genus        : Embelia 
Species      : ribes 
  
Vernacular Name:  
            San: Vidangah, vellah;  Eng:Embelia,Hin:Vayvidamg, Bhabhiramg,   
Kan:Vayuvidanga  Mal: Vital;  Tam:Vayu-vilamga Tel: Vayuvidangamu, Vidanga 
  
- 
 
-  
- - -  
- 
 
 
 
 
 
- 
 
-  
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Chemical Constituents:  
            A flatoxin B1,  
            Embelin 2,5-isobutylamine salts,  
            Christembine, 
            Homoembelin,  
            Vilangine,   
            Quercitol 
 
Uses:  
               The fruits are acrid, astringent, bitter,thermogenic, anthelmintic, depurative, 
brain tonic, digestive, carminative, stomachic, diuretic, contraceptive, rejuvenating, 
alterant, stimulant, alexeteric, laxative, anodyne, febrifuge and tonic, and are useful in 
vitiated conditions of kapha and vata, helminthiasis, skin diseases, leprosy, pruritus, 
nervous debility, amentia, dyspepsia, flatulence, colic, constipation, strangury, tumours, 
asthma, bronchitis, dental caries, odontalgia, hemicranias, dyspnoea, cardiopathy, 
psychopathy, ringworm infestation fever, emaciation and general debility. The roots are 
acrid, astringent, thermogenic and stomachic, and are useful in vitiated conditions of Vata, 
odontalgia, colic, flatulence and dyspepsia. The leaves are astringent, thermogenic, 
demulcent and depurative, and are useful in pruritus, skin diseases and leprosy. 
 
Pharmacological Studies 
 
Antianthelmintic activity 
 
        The ethanolic extract of the seeds of Embelia ribes (10-200 mg/mL) exhibited potent 
anthelmintic activity. This result may lend support for the traditional use of the plant as an 
anthelmintic. 
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INGREDIENTS OF ELISEVIKUDINEER 
 
              
 
        Figure 5: Elisevielai                                               Figure 6 :Kadukai 
 
 
 
 
          
 
           Figure 7: Nelli vatral                           Figure 8: Thandrikai 
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  Figure 8: Murungaipattai                        Figure 9: Vaaividangam 
 
 
                                      PREPARED MEDICINE 
 
                      
 
Figure:10: Elisevikudineer chooranam                           Figure:11: Elisevi kudineer 
 
 
 
 
 
    Materials  
        And  
    Methods 
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                           4.MATERIAL AND METHODS               
               Keerinoi is one of   the   common   illnesses   in children. In our NIS OPD, a 
number of cases are approaching Kuzhandhai maruthuvam department daily with the 
Symptomps of Keerinoi. Hence it was proposed to study about   the disease. A  Protocol   
was prepared and submitted be fo re IEC of   National Institute of Siddha and approval 
for the study was obtained vide approval No:NIS/IEC/8-14/23-26-08-2014.The trial was 
registred in Clinical trial Registry of India with Reg .No.CTRI/2016/05/006934. After 
obtaining  approval  from   the  committee, the  clinical  study on Keerinoi ( Thread 
worm)in  children with  the  drug  Elisevi kudineer was carried out  as  per  the protocol. 
  
4.1AUTHENTICATION OF INGREDIENTS IN FORMULATIONS  
                To confirm the identity of herbal species used in the formulations by a 
Taxonomist using organoleptic characters and authenticate them.  
 
NAME OF THE TRIAL DRUG: ELISEVI KUDINEER.  
INGREDIENTS:  
 Elisevi elai          (Merremia emarginata) -  2gm         
 Murungaipattai   (Moringa oleifera)              - 2gm 
 Kadukaaithol      (Terminalia chebula)          -  2gm     
 Thaanrikaaithol   (Terminalia bellirica)         - 2gm      
 Nellivatral           (Phyllanthus emblica )        - 2gm     
 Vaaividangam       (Embelia ribes)                  
 
SOURCE OF TRIAL MEDICINE : 
           The required drugs for preparation of  ELISEVI KUDINEER  was purchased 
from a raw drug shop and raw drugs were authenticated by  Botanist National Intitute of 
Siddha. The  medicine was prepared in Gunapadam lab of National Institute of Siddha 
after proper purification.The prepared medicine was  been authenticated by the concerned 
Head of the Dept for its completeness.  
 
PURIFICATION PROCESS OF RAW MATERIALS 
              Purification method has been adopted from literary reference.  
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PURIFICATION METHOD  
        Elisevi elai           -          The leaves were cleaned with white cloth. 
       Murungai pattai    -           The skin of the bark was removed. 
       Kadukaai              -          Soaked  in rice water and the seeds were removed. 
       Nellivatral             -          Boiled  with milk and  the seeds were removed. 
Thaandri                 -          Soaked in thazhai vizhuthu juice for 3 hours and remove    
the  seed. 
           Vaaividangam       -          Dried  in sunlight  
 
4.2 STANDARD OPERATING PROCEDURE OF ELISEVI KUDINEER : 
           Above mentioned drugs are purified by purification method. All the purified drugs 
are powdered in decoction powder form except vaaividangam and keep in a clean glass 
container. Vaaividangam is powdered in chooranam form and keep in glass container. 
 
METHOD OF PREPARING KUDINEER: 
          The above decoction powder was mixed with 160 ml of water and boiled until one 
eighth of decoction (20 ml)and add vaaividangam powder was added at the time of 
consumption. 
 
Dosage  : 8  -10 years (10 ml with 1gm vaaividangam) 
                   10-12 years (2  ml with gm vaaividangam)  
** Dose calculation for pediatric group is based on Age, formula mentioned in the 
Gunapadam Thathu vaguppu text.  
Duration :  3 days. 
 
DRUG STORAGE: 
 The trial drug ELISEVI KUDINEER  powder is stored in clean and dry container. 
DISPENSING 
      The ELISEVI KUDINEER  chooranam  is given in separate pockets of airlock cover 
and vaaividangam chooranam was given separately as 1 gm pockets covered with butter 
paper. 
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4.3 PRECLINICAL STUDIES  
          A. Physicochemical Analysis 
        B. Pharmacological Activity 
        C. Chemical Analysis 
 
4.3.A.PHYSICOCHEMICAL ANALYSIS OF ELISEVI KUDINEER  
The Physicochemical analysis of the drug Elisevi kudineer was done at Siddha 
Central Research Institute, Arumbakkam Chennai. Since the form of the drug is in 
kudineer chooranam the parameters such as Ash, Loss on drying, Acid insoluble Ash, 
Water Soluble Extraction, Alcohol Soluble Extraction, pH was done using Quality control 
methods for medicinal plants materials. 
 
1.Loss on drying 
            Loss on dying is the loss of mass expressed as percent w/w. About 10g of drug 
sample was accurately weighed in a dried and tared flat weighing bottle and dried at 1050C 
for 5hrs. Percentage was calculated with reference to initial weight. 
 
2.Total Ash    
            Take about 2 or 3 g, accurately weighed, of the ground drug in a tarred platinum or 
silica dish previously ignited and weighed. Scatter the ground drug in a fine even layer on 
the bottom of the dish. Incarnated by gradually increasing the heat-not exceeding dull red 
heat- until free from carbon, cool and weigh. 
             If a carbon free ash cannot be obtained in this way, exhaust the charred mass with 
hot water, collect the residue on an ash less filter paper, increate the residue and filter 
paper, add the filtrate, evaporate to dryness and ignite at low temperature. Calculate the 
percentage of ash with reference to the air dried drug. 
 
3.Acid insoluble Ash  
                 Boil the total ash with for five minutes with 25 ml of dilute hydrochloric acid, 
collect the insoluble matter in a Gooch crucible or on an ash less filter paper, wash with 
hot water, ignite, and weigh. Calculate the percentage of acid- insoluble ash with reference 
to the air dried drug. 
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4.Water Soluble Extractive 
               1gm of air dried drug, coarsely powered was macerated with 100ml of distilled 
water in a closed flask for twenty four hours shaking frequently. Solution was filtered and 
25 ml of filtrated was evaporated in a tarred flat bottom shallow dish, further dried at 1050 
C and weighted .The percentage of water soluble extractive was calculated with reference 
to the air dried drugs 
 
5.Alcohol Soluble Extractive 
         1 gm of air dried drugs, coarsely powdered was macerated with 100 ml. alcohol in 
closed flask for 24 hrs. With frequent shaking. It was filtered rapidly taking precaution 
against loss of alcohol. 25ml of filtrate was then evaporated in a tarred flat bottom shallow 
dish, dried at 1050C and weighted. The percentage of alcohol soluble extractive was 
calculated with reference to air dried drug.  
 
6.pH 
                The pH of the formulations in 1% w/v and 10% w/v of water soluble portions was 
determined using simple glass electrode pH meter.         
  
4.3.B.PHARMACOLOGICAL ACTIVITY OF ELISEVI KUDINEER 
  
Preparation of the plant extract: 
       One gram of  product  of  Elisevi kudineer  sample material was extracted with 
20 mL  aqueous  for 1 min using an Ultra Turax mixer (13,000 rpm) and soaked overnight 
at room temperature. The sample was then filtered through Whatman No. 1 paper in a 
Buchner funnel. The filtered solution was evaporated under vacuum in a rota-vator at 40 
°C to a constant weight and then dissolved in respective solvents. The dissolving rate of 
the crude extracts was approximately 100 %. The solution was stored at 18 °C until use. 
Worm collection          
               Adult live nematodes, Enterobius vermicularis were collected from Perambur 
slaughter house, Chennai. They were opened in a plastic bucket separately and the 
contents were washed up in tap water. The process was repeated for several times until the 
sediment becoming transparent. Then the adult worms were collected with the help of a 
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needle and placed in a petridish containing PBS (Phosphate Buffer Saline). Petridish 
containing the worms was kept in incubator at 38°C until required for experiment on the 
same day.  
In-vitro screening with aqueous extract of Elisevi kudineer sample was performed 
using Enterobius vermicularis. The aqueous sample extract were used at various 
concentrations such as 25 mg/ml (2.5%), 50 mg/ml (5%) and100 mg/ml (10%), distilled 
water (control) and reference standard Albendazole (2.5%, 5% and 10%) using adult 
nematode worms in petridish. Observations were made for time taken to paralysis and 
death of individual worms. Paralysis was said to occur when the worms did not revive 
even in normal saline. Death was concluded when the worms lost their motility followed 
with fading away of their body colour. 
 
4.3.C.CHEMICAL ANALYSIS OF ELISEVI KUDINEER  
             Chemical Analysis of Elisevi kudineer was done at the Biochemistry lab at 
National Institute of Siddha, Chennai by the method of Kolkate. 
Preparation of Extract: 
     5ml of sample was taken in a 250ml clean beaker and added with 50ml of 
distilled water. Then it is boiled well for about 10 minutes. Then it is cooled and filtered in 
a 100ml volumetric flask and made up to 100ml with distilled water. This preparation is 
used for the qualitative analysis of acidic/basic radicals and biochemical constituents in it. 
Procedure:  
Test for Silicate 
             A 2ml of the sample was shaken well with distilled water. 
Action of Heat: 
           A 2ml of the sample was taken in a dry test tube and heated gently at first and then 
strong. 
Action of Heat: 
           A 2ml of the sample was taken in a dry test tube and heated gently at first and then 
strong. 
Ash Test:  
            A filter paper was soaked into a mixture of extract and dil. cobalt nitrate solution 
and introduced into the Bunsen flame and ignited 
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Test for Acid Radicals 
Test for Sulphate: 
            2ml of the above prepared extract was taken in a test tube to this added 2ml of 4% 
dil ammonium oxalate solution 
 Test for chloride: 
           2ml of the above prepared extracts was added with 2ml of dil.HCl is added until the 
effervescence ceases off. 
Test for Phosphate: 
         2ml of the extract were treated with 2ml of dil.ammonium molybdate solution and 
2ml of con.HNo3. 
Test for carbonate: 
          2ml of the extract was treated with 2ml of dil. magnesium sulphate solution. 
Test for Nitrate: 
        1gm of the extract was heated with copper turning and concentrated H2So4 and 
viewed the test tube vertically down. 
II.Test for Basic radicals 
Test for lead: 
         2ml of the extract was added with 2ml of dil.potassium iodine solution. 
Test for copper: 
         One pinch (25mg) of extract was made into paste with con. HClin a watch glass and 
introduced into the non-luminuous part of the flame. 
Test for Aluminium: 
           To the 2ml of extract dil.sodium hydroxide was added in 5 drops to excess. 
Test for Iron:  
           a. To the 2ml of extract add 2ml of dil.ammonium solution  
           b. To the 2ml of extract 2ml of thiocyanate solution and 2ml of con HNo3 is added. 
Test for Zinc: 
          To 2ml of the extract dil.sodium hydroxide solution was added in 5 drops to excess 
and dil.ammonium chloride is added.  
Test for Calcium: 
        To 2ml of the extract was added with 2ml of 4% dil.ammonium oxalate solution 
Test for Magnesium: 
        To 2ml of extract dil.sodium hydroxide solution was added in drops to excess.  
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Test for Ammonium: 
        To 2ml of extract 1 ml of Nessler's reagent and excess of dil.sodium hydroxide 
solution are added. 
Test for Potassium: 
         A pinch (25mg) of extract was treated of with 2ml of dil.sodium nitrite solution and 
then treated with 2ml of dil.cobalt nitrate in 30% dil.glacial acetic acid. 
 Test for Sodium: 
         2 pinches (50mg) of the extract is made into paste by using HCl  and introduced into 
the blue flame of Bunsen burner. 
 Test for Mercury: 
         2ml of the extract was treated with 2ml of dil.sodium hydroxide solution. 
 Test for Arsenic: 
          2ml of the extract was treated with 2ml of dil.sodium hydroxide solution 
III. Miscellaneous 
Test for Starch: 
      2ml of extract was treated with weak dil.Iodine solution. 
Test For Reducing Sugar: 
       5ml of Benedict's qualitative solution was taken in a test tube and allowed to boil for 2 
minutes and added 8 to 10 drops of the extract and again boil it for 2 minutes. The colour 
changes are noted. 
Test for the Alkaloids: 
      a) 2ml of the extract was treated with 2ml of dil.potassium Iodide solution. 
      b) 2ml of the extract was treated with 2ml of dil.picric acid. 
     c) 2ml of the extract was treated with 2ml of dil.phosphotungstic acid. 
Test for Tannic Acid: 
      2ml of extract was treated with 2ml of dil.ferric chloride solution. 
Test for Unsaturated Compound: 
      To the 2ml of extract 2ml of dil.Potassium permanganate solution is added. 
Test for AminoAcid: 
      2 drops of the extract was placed on a filter paper and dried well. 20ml of Burette 
reagent is added. 
Test for Type of Compound: 
      2ml of the extract was treated with 2 ml of dil.ferric chloride solution 
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4.4.CLINICAL STUDIES:  
POPULATION AND SAMPLE :  
The population consists of paediatric patients attending the OPD of Ayothidoss 
Pandithar Hospital, National Institute of Siddha, Chennai-47.  
The sample consists of patients between 8  12 yrs age group fulfilling more than 
three of the inclusion criteria and having positive investigation of ova and cyst of worms 
in feces.  
Sample size : 40 Patients  
Study place: OPD & IPD Of Ayothidoss pandithar hospital, National Institute of 
Siddha,Tambaram Sanatorium, Chennai  47.  
 
INCLUSION CRETERIA:        
Age: between 8-12 years 
Having complaints of Loss of appetite 
Presence of peri anal itching   
Pain around the umbilicus       
Teeth grinding during sleep  
Bed wetting 
History of passing worms in the stools 
     Positive investigation of ova and cyst of worms. 
   
EXCLUSION CRITERIA:  
           Amebiasis 
           Patient infested with round worm 
           Patient infested with hook worm 
           Negative investigation of ova and cyst 
WITHDRAWAL CRITERIA 
            Signs of profuse dehydration. 
            Poor patient compliance. 
            Patient turned unwilling to continue in the course of clinical trial. 
            Occurrence of any adverse reaction  
            Other intestinal complaints 
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Study Design 
              An Open clinical trial  
 
NAME OF THE TRIAL DRUG: ELISEVI KUDINEER.  
Dosage  :    8  -10 years (10 ml with 1gm vaaividangam) 
                    10-12 years (2  ml with  gm vaaividangam).  
Duration :  3 days. 
  
ASSESMENTS AND INVESTIGATIONS  
A. Clinical assessment  
B. Routine investigations  
C. Specific investigations  
D. Siddha method of assessment  
 
A.CLINICAL ASSESSMENT 
 Presence of peri anal itching 
 Pain around the umblicus 
 Loss of appetite 
 Teeth grinding during sleep. 
 Bed wetting.  
 History of passing worms in the stools 
 
B.ROUTINE INVESTIGATION 
  
I. MOTION TEST:  
          OVA 
          CYST 
          OCCULT BLOOD 
Laboratory diagnosis [* Based on the WHO recommendations]  
                   Helminthic eggs are often easier to find and identify because of their size and 
their distinctive morphological features. While direct smears of fresh faeces will often 
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demonstrate helminth eggs, it is usually more efficient for laboratories to do a simple 
concentration to avoid overlooking parasites that may be present in very small numbers. 
Direct faecal smears  saline and iodine wet mount preparations Procedure  
1). With a wax pencil or other marker, write the patient's name or identification number 
and the date at the left hand side.  
2). Place a drop of saline in the centre of the left half of the slide and place a drop of 
iodine solution in the centre of the right half of the slide. Materials and reagents: Wooden 
applicator sticks or matchesMicroscope slides (75x25 mm) CoverslipsPens or markers for 
indelible marking Dropping bottles containing: Isotonic saline solution (0.85%; 
8.5g/l)Lugol's iodine (1% solution)  
3). With an applicator stick or match, pick up a small portion of faeces (approximately 2 
mg which is about the size of a match head) and add it to the drop of saline: add a similar 
portion to the drop of iodine. Mix the faeces with the drops to form suspensions.  
4). Cover each drop with a cover slip by holding the coverslip at an angle, touching the 
edge of the drop, and gently lowering the coverslip onto the slide so that air bubbles are 
not produced.  
5). Examine the preparation with the 10X objective in a systematic manner (either up and 
down or laterally) so that the entire coverslip area is observed. When organisms are seen, 
switch to higher magnification top see the more detailed morphology of the object in 
question. 
C.SPECIFIC INVESTGATIONS 
          SCOTCH TAPE TEST  
I. Materials  
A. Patient specimen collection requires the following:  
used).  
2. Microscope slide(s) with frosted end for labeling.  
3. Sterile urine cup or slidecontainer.  
II. Specimen Collection  
A. Pinworm (Enterobius vermicularis) eggs are deposited around the perianal region; eggs 
are rarely found in stools, and stool is not appropriate specimen for the diagnosis of 
pinworm.  
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 method gives the best recovery of eggs if used before defecation, 
bathing or dressing in the morning.  
C. Label the slide in pencil with the patient name, medical record number, and date.  
D. Firmly press the sticky side of a length of clear, transparent tape to the skin, around the 
folds of the anus.  
E. Apply the tape, sticky side down, to the clear section of the labeled microscope slide. 
Cut off any excess tape that may overlap the edges of the slide.  
F. Place the slide in the specimen cup/container, and deliver to the laboratory along with 
an appropriate requisition.  
 
D.SIDDHA METHOD OF ASSESSMENT: 
             Nilam,  
               Kalam,  
               Uyirthathukkal,  
               Udal thathukkal,  
               Envagai thervugal 
. 
OUTCOME : 
 Primary     - Results and observation during the study inclusive of clinical     
improvement etc 
 Secondary - Clinical Efficacy of the trial drug and its side effects if any  
 
STUDY ENROLLMENT :  
  In this open clinical trial, patients reporting at the OPD, between the age group 
of 6  12 , with the clinical symptoms of presence of peri anal itching, loss of 
appetite, pain around the umbilicus, teeth grinding during sleep (Bruxism) had 
been examined clinically and scotch tape test had done. 
  The patients who are enrolled were be informed about the study, trial drug, 
possible outcomes and the objectives of the study in the language and terms 
understandable to patient informant  
  After ascertaining the patient informant willingness, informed consent would 
be obtained in writing from them in the consent form.  
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  All the patients are given with Registration number of the study. Address, 
Phone number of the patient has been collected, and Doctors phone number is 
given to the patient as to report easily should any complications arise.  
  Complete clinical history, complaints and duration, examination findings and 
their profile had been recorded in the prescribed Proforma in the history and 
clinical assessment forms separately.  
  Patients are advised to take the trial drug and appropriate dietary advice has 
been given according to the patient informant understanding.  
 
CONDUCT OF THE STUDY:  
                      
ELISEVIKUDINEER
day patient is requested to attend the OPD for clinical assessment and recorded in the 
clinical assessment form and prognosis is noted . s informant are requested to 
bring back the un-consumed trial drug if any. For IP patients the drug are provided daily 
and prognosis is noted Laboratory investigations are done on 1st day,7 th day & 15th day 
of the trial and are recorded. After the completion of the treatment, the patient is advised 
to visit the OPD for further follow-up.  
 
DATA MANAGEMENT: 
 
 After enrolling the patient in the study, the profile of each patient has been 
maintained and filed. Study No. and Patient No. has been entered on the top of 
file for easy identification. Whenever study patient visits OPD during the study 
period, the respective patient file was been taken and necessary recordings have 
been made at the assessment form or other suitable form. 
 The screening forms was been filed separately. 
 The Data recordings in all forms was been monitored and scrutinized by HOD, 
Dept of Kuzhanthai maruthuvam . 
 
ADVERSE EFFECT/SERIOUS EFFECT MANAGEMENT: 
        There is no development of any adverse reaction. 
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ETHICAL ISSUES 
     
     1. To prevent any infection, proper  sterilized  lab equipments was been used                        
2. No other external or internal medicines was given to the patient.  
      3. The data collected f  been kept confidentially. The 
 been Informed  about the diagnosis, treatment and follow-up.  
4. After the consent of the  consent form), patient was 
enrolled in the study.  
 
6. Treatment is  provided free of cost.  
7. In conditions of treatment failure , adverse reactions, patients will be given  
alternative treatment at the National Institute of Siddha with full care.  
 
DATA COLLECTION FORMS:-  
 
FORM I: SCREENING & SELECTION PROFORMA.  
FORM II : CONSENT FORM.  
FORM III: HISTORY PROFORMA.  
FORM IV: CLINICAL ASSESSMENT FORM. 
FORM V: LABORATORY INVESTIGATION FORM.  
FORM VI: PATIENT INFORMATION SHEET.  
FORM VII: WITHDRAWAL FORM.  
FORM VIII: ADVERSE EFFECT FORM.  
FORM IX: ASSENT FORM 
                                       
                                        
 
 
 
 
 
                     
 
 
     Results  
        And                   
Observations 
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                       5.RESULTS AND OBSERVATION  
PHYSICO CHEMICAL ANALYSIS OF ELISEVI KUDINEER 
 
PHARMOCOLOGICAL ACTIVITY OF ELISEVIKUDINEER            
Test Substance 
 
Conc (mg/ml) 
 
Time taken for 
paralysis (minutes) 
 
Time taken for 
death (minutes) 
 
Distilled 
Water 
(Control)  
- - - 
Albendazole 
(Standard)  
 
25 46.02 51.23 
 
50 37.14 33.46  
 
100 12.17 26.27  
 
 
S.NO 
 
                            PARAMETER 
 
MEAN 
 
1. 
 
Loss on Drying at 1050 C 
 
8.69% 
 
2. 
 
Total Ash 
 
4.79% 
 
3. 
 
Acid insoluble Ash 
 
0.53% 
 
4. 
 
Water Soluble Extractive 
 
28.85% 
 
5. 
 
Alcohol Soluble Extractive 
 
20.45% 
 
6. 
 
Ph 
 
3.12 
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Aqueous 
extract  
 
25 48.61 53.67  
 
50 39.38  
 
35.17  
 
100 15.85  
 
28.10  
 
 
CHEMICAL ANALYSIS  
Results of Acid radicals studies 
S.NO Parameter Observation Result 
1 Test for Sulphate                   -  
Negative 
2 Test for Chloride 
 
Cloudy appearance    
present 
 
Positive 
3 Test For Phosphate 
 
Cloudy  yellow     
appearance present 
 
Posititive 
4 Test For Carbonate   
 
 
 
                   - 
 
Negative 
 
5 Test For Nitrate  
- 
Negative 
6 Test for Sulphide  
- 
Negative 
7 Test For Fluoride &oxalate 
 
 
- 
Negative 
8 Test For Nitrite 
 
- 
 
Negative 
9 Test For Borax 
 
- Negative 
Interpretation 
The acidic radicals test shows the presence of  Chloride, Phosphate. 
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Results of basic radicals studies. 
 
Interpretation 
              The basic radical test shows the presence of  Iron, and absence of heavy metals 
such as lead,  arsenic and mercury. 
 
 
S.NO Parameter Observation Result 
1 Test for Lead  
- 
Negative 
2 Test for Copper 
 
- Negative 
3 Test For Aluminium 
. 
 
- 
 
Negative 
4 Test For Iron 
. 
Red colour appeared Positive 
5 Test For Zinc  
- 
Negative 
6 Test for Calcium  
- 
Negative 
7 Test For Magnesium 
 
- Negative 
8 Test For Ammonium 
 
- 
 
Negative 
 
9 Test For Potassium 
 
- Negative 
10  Test For Sodium 
 
 
- 
 
Negative 
11 Test For Mercury 
 
 
- 
 
Negative 
12 Test For Arsenic 
 
 
- 
 
Negative 
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Miscellaneous 
 
S.NO Parameter Observation Result 
1 Test for Starch  
- 
Negative 
2 Test for Reducing sugars 
 
- Negative 
3 Test For Alkaloids 
 
Yellow colour developed Positive 
4 Test For Tannic acid 
 
Blue-black precipitate 
obtained 
Positive 
5 Test for unsaturated 
compounds 
 
- 
Negative 
6 Test for Amino acid                     - Negative 
7 Test For type of compounds 
 
Blue colour developed. Positive 
 
Interpretation 
            The Miscellaneous test shows the presence of  Alkaloid, Tannic acid, Type of 
Compounds.  
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                         CLINICAL STUDIES 
 
          For this clinical study 40 cases were selected and treated in the In-patient 
department and Out-patient department of P.G Kuzhanthai Maruthuvam, Ayothidoss 
Pandithar Hospital National Institute of Siddha, Chennai 47. Results were observed with 
respect to the following criteria  
 
Results were observed with respect to the following criteria:  
 
1. Age distribution  
2. Sex distribution  
3. Religious distribution  
4. Socio-economic status  
5. Dietary habits  
6. Reference to Thinai 
7. Seasonal reference  
8. Habitual Disorders  
9. Reference to Duration of illness  
10. Reference to Mukkutra Kaalam  
11. Reference to Udal Kattukal  
12. Reference to Envagai Thervukal  
13. Neikuri reference  
14. Reference to clinical features  
15. Refence to Lab investigations  
16. Statistical analysis  
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Table1. Distributions of patients with Keerinoi according to Age  
 
 
 
 
 
 
 
 
Inference  
             Among the 40 patients treated, 21 cases (52.5%) belongs to 8 years, 2 cases (9%) 
belongs to 9 years, 6 cases (15%) belongs to 10 years, 8 cases (20%) belongs to 11 years 
and 3 cases (7.5%) belongs to 12 years.  
 
 
 
 
 
 
Years Years 
Years 
Years 
Years 
 
 
  
 
AGE DISTRIBUTION 
S.No Age No of cases Percentage 
1. 8 Years 21 52.5% 
2. 9Years 2 5% 
3. 10 Years 6 15% 
4. 11 Years 8 20% 
5. 12 Years  3 7.5% 
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Table 2 Distributions of patients with Keerinoi according to Gender 
 
 
S.No Sex No of Cases Percentage 
1. Male Child 18 45% 
2. Female Child 22 55% 
 
 
 
 
 
 
 
Inference: 
          Among the 40 patients selected 55% were male children and 45% were female 
children 
 
 
 
 
45% 
55% 
SEX DISTRIBUTION 
Male Child 
Female Child 
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Table 3. Distribution of patients with Keerinoi according to Religion 
 
 
 
 
 
 
 
 
 
 
Inference 
            Among 40 cases, 87.5 % of the cases belongs to Hindu religion , 7.5 % belongs to 
Muslim and 5 % belongs to Christian religion 
 
 
 
 
 
Hindu 
Muslim 
Christian 
 
 
 
RELIGION DISTRIBUTION 
S.No Religions No of Cases Percentage 
1. Hindu 35 87.5% 
2. Muslim 3 7.5% 
3. Christian 2 5% 
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Table 4. Distribution of patients with Keerinoi according to socio-
economic status 
  
S.No 
Socio-economic 
Status 
No of Cases Percentage 
1. Lower 10 25% 
2. Middle class 18 45% 
3. Upper 
12 30% 
 
 
 
 
 
 
 
 
Inference  
              Out of 40 cases, 30% of cases belong to Upper class status, 45 % of the cases 
belong to middle class status and 25 % of the cases belong to low economic status.  
 
 
Lower  
25% 
Middle Class  
45% 
Upper  
30% 
Socio- economic Status 
lower 
Middle Class 
upper 
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Table 5. Distribution of patients with Keerinoi according to Diet  
reference 
 
  
  
 
 
 
 
 
Inference 
             Out of 40 cases , 75 % of the cases are with Mixed diet and about 25 % of the 
cases are with Vegetarian diet habit. 
 
 
 
 
Vegetarian  
25% 
Mixed  
75% 
Dietary Habit 
Vegetarian 
Mixed 
S.No Food habits No.of Cases Percentage 
1. Vegetarian 10 25% 
2. Mixed 30 75% 
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Table 6. Distribution of patients with Keerinoi according to Nilam 
 
Nilam No of cases Percentage 
Kurinji  0 0% 
Mullai  0 0% 
Marutham  9 22.5% 
Neithal  31 77.5% 
Paalai  0 0% 
 
 
 
 
 
 
 
Inference  
        Among the 40 cases, 22.5% belongs to Marutha nilam and 77.5% belongs to Neithal 
nilam. 
 
 
 
 
 
Kurinji Mullai 
Marutham 
Neithal 
Paalai 
  
 
 
 
Nilam 
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Table 7. Distribution of patients with Keerinoi according to Paruvakalam 
  
 
 
 
 
 
 
Inference 
           Out of 40 patients treated, 19 patients had been treated in Munpani kaalam (47.5%), 
16 patients in Pinpani kaalam (40%) and 5 patients in Elavenil kaalam (12.5). 
 
 
 
 
 
  
 
 
 
 
Paruvakalam 
S.No Paruvakaalam No. of cases Percentage 
1. Karkaalam (Avani  puratasi) 0 0% 
2. Koothirkaalam (Iyppasi  karthikai) 0 0% 
3. Munpani (Markazhi  Thai) 19 47.5% 
4. Pin pani (Masi  Panguni) 16 40% 
5. Elavenil (Chitirai, Vaigasi) 5 12.5% 
6. Mudhuvenil (Aani, Aadi) 0 0% 
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Table 8. Distribution of patients with Keerinoi according to Habits 
  
Habits No of cases Percentage 
1.Nail biting 15 37.5% 
2.Thumb sucking 2 5% 
3.Pica 7 17.5% 
4.Bed wetting 19 47.5% 
5.Sleep activity 0 0% 
 
 
 
 
 
 
 
 
Inference 
       Out of 40 cases , 37.5% of cases had an habit of Nail bitting, 5% cases had Thumb 
sucking, 17.5% had pica and Bed wetting for about 47.5%. 
 
 
 
 
 
Nail biting Thumb 
sucking Pica Bed wetting 
Sleep 
activity 
 
 
 
 
 
Habits 
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Table 9. Distribution of patients with Keerinoi according to Duration of 
illness 
 
 
 
 
 
 
Inference  
          Among 40 cases, 72.5 % of cases had their illness within 6 months ,25 % of cases 
had their illness durated between 7 to 12 months, and 2.5% of cases had their illness 
durated between 13 to 36 months 
 
 
 
 
 
 
 
-6 months 
-12 months 
-36 months 
 
 
 
DURATION OF ILLNESS 
S.No Duration No of Cases Percentage 
1. 0-6 months 29 72.5% 
2. 7-12 months 10 25% 
3. 13-36 months 1 2.5% 
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Table 10a. Distribution of patients with Keerinoi according to derangement of  
Vatham 
 
 
 
 
 
Inference:  According to vatham, derangement of Abanan, Samanan was 100%, 
Viyanan was affected 57.5% Uthanan was affected in 27.5%, Kirukaran was affected in 
67.5%. 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
Affected Vatham 
S.No 
Classification of 
vatham 
No. of Cases Percentage 
1. Piranan 0 0% 
2. Abanan 40 100% 
3. Viyanan 23 57.5% 
4. Uthanan 11 27.5% 
5. Samanan 40 100% 
6. Nagan 0 0% 
7. Koorman 0 0% 
8. Kirukaran 27 67.5% 
9. Devathathan 0 0% 
10. Thananjeyan 0 0% 
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Table 10b. Distribution of patients with Keerinoi according to 
derangement of Pitham 
 
S.No Types of pitham No.of Cases Percentage 
1. Analapitham 28 70% 
2. Ranjagam 12 30% 
3. Saathagam 0 0% 
 
4. 
Prasagam 
 
11 27.5% 
5. Alosagam 0 0% 
 
 
 
 
 
 
 
Inference  
         Among 5 types of Pitham Analam affected by 70% , Ranjaga pitham by 30% and 
Pirasagam by 27.5%. 
 
 
 
 
 
Analapitham Ranjagam 
Saathagam 
Prasagam 
Alosagam 
 
 
 
 
 
Affected Pitham 
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Table 10c. Distribution of patients with Keerinoi according to 
derangement of Kabam 
S.No Types of Kabham No.of Cases Percentage 
1. Avalambagam 0 0% 
2. Kilethagam 28 70% 
3. Pothagam 0 0% 
4. Tharpagam 0 0% 
5. Santhigam 0 0% 
 
 
 
 
 
 
 
 
Inference  
              Avalambagam and Kilethagam was affected in 28 cases about 70 %.  
 
 
 
 
   
 
 
 
Affected Kabam 
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Table 11. Distribution of patients with Keerinoi according to 
derangement of Ezhu Udalkattugal 
 
S.No Udal kattugal No.of Cases Percentage 
1. Saaram 40 100% 
2. Senneer 12 30% 
3. Oon 0 0% 
4. Kozhuppu 0 0% 
5. Enbu 0 0% 
6. Moolai 0 0% 
7. 
Sukkilam  / 
Suronitham 
0 0% 
 
 
 
 
 
 
Inference; In seven Udal Kattukal, Saaram and Senneer were affected among 100 % and 
30% respectively. 
 
 
 
 
 
 
 
 
     
Reference to UDAL KATTUGAL 
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Table 12. Distribution of patients with Keerinoi according to 
derangement of Enn vagai thervugal 
S.No 
Enn Vagai 
Thervugal 
No.of Cases Percentage 
1 Naa 12 30% 
2 Niram 12 30% 
3 Mozhi 0 0% 
4 Vizhi 12 30% 
5 Sparisam 0 0% 
6 Malam(Constipation) 40 100% 
7 Moothiram 0 0% 
8 
Naadi  
 
0 0% 
 
 
 
Inference 
Among the Ennvagai thervukal, Naa was affected in 30% of cases, Niram in 30% 
of cases and Vizhi were affected in 30 % of the cases. Malam was affected in all 40 cases 
(100%). 
 
 
 
  
 
 
 
 
  
Enn Vagai Thervu 
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Table 13. Distribution of patients with Keerinoi according to observation 
of Neikuri analysis 
 
S.No 
Character of 
urine 
Neikuri 
Reference 
No.of Cases Percentage 
1. 
Spreads like 
snake 
Vatha Neer 
11 
27.5% 
2. 
Spreads like 
ring 
Pitha Neer 
22 
55% 
3. Static as pearl Kaba Neer 7 17.5% 
 
 
 
 
 
 
Inference   
            Among the 40 patients in Neikuri 27.5% of cases were seen as Vatha neer, 55% of 
cases were seen as Azhal neer and 17.5% were Kaba neer 
 
 
 
 
 
 
 
 
 
Vatha Neer Pitha Neer Kaba Neer 
 
 
 
Reference to NEIKURI 
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Table14. Distribution of patients with Keerinoi according to Clinical features 
 
Sl.No 
Clinical 
Features 
No of  
patients 
observed 
before 
treatment 
percentag
e 
No of  
patients 
observed 
after 
treatment 
 
Percentage 
1. Peri Anal Itching 40 100% 4 10% 
2 Pain around the 
umbilicus 
36 90% 0 0% 
3 Loss of appetite 31 77.5% 14 35% 
4 Teeth grinding 
during sleep 
27 67.5% 1 2.5% 
5 Bed wetting 19 47.5% 11 27.5% 
6 Passage of worms 
in stools 
36 90% 0 0% 
 
 
 
Inference: The clinical features recorded among the 40 cases revealed Peri anal 
itching(100%), Pain around the umbilicus (90%),Loss of appetite (77.5%), Teeth grinding 
during sleep (67.5%), Bed wetting(47.5%),Passage of worms in stools(90%) before 
treatment . The symptoms showed a good prognosis after treatment with reduced 
percentage of clinical features as 10% 0 % , 35%, 2.5%, 27.5%, 0% respectively. 
 
   
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Peri Anal 
Itching 
Pain 
around the 
umbilicus 
Loss of 
appetite 
Teeth 
grinding 
during 
sleep 
Bed 
wetting 
Passage of 
worms in 
stools 
Before  
Treatment 
After  
Treatment 
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Table 15. Distribution of patients with Keerinoi according to Laboratory 
investigations 
 
 
 
 
 
Inference  
    Out of 40 cases , 70% of the cases on investigation at I interval shows absence of ova 
and cyst and 72.5 % of the cases shows absence by II interval. 
               
 
 
 
 
 
 
 
 
 
 
BEFORE TREATMENT AFTER TREATMENT  
ST INTERVAL 
AFTER TREATMENT  
ND INTERVAL 
Laboratory Investigations 
 
S.NO 
 
Before treatment 
After treatment 
negative investigation 
@ 1st interval 
After treatment  
negative investigation 
@ 2nd interval 
 
1 
 
No of 
cases 
   
Percentage                
 
No of 
cases 
 
Percentage 
 
No of 
cases 
 
Percentage 
  
40 
 
100 
 
28 
  
70 
 
29 
 
72.5 
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LABORATORY INVESTIGATIONS RESULTS 
SCOTCH TAPE TEST RESULTS  
S.no Op number 
 
Before treatment 
 
After treatment 
negative 
investigation @         
1st interval 
After treatment 
negative 
investigation @        
2nd interval 
1 H30799 Pin worm ova + Negative Negative 
2 H12097 Pin worm ova + Negative Negative 
3 H16270 Pin worm ova + Negative Negative 
4 G90685 Pin worm ova + Negative Negative 
5 E90508 Pin worm ova + Pin worm ova + Pin worm ova + 
6 E076632 Pin worm ova + Negative Negative 
7 H15753 Pin worm ova + Negative Negative 
8 H13904 Pin worm ova + Negative Negative 
9 G91767 Pin worm ova + Negative Negative 
10 G89242 Pin worm ova + Pin worm ova + Pin worm ova + 
11 H22352 Pin worm ova + Negative Negative 
12 G89105 Pin worm ova + Negative Negative 
13 G89538 Pin worm ova + Negative Negative 
14 H30286 Pin worm ova + Pin worm ova + Pin worm ova + 
15 G97816 Pin worm ova + Negative Negative 
16 H09253 Pin worm ova + Negative Negative 
17 H28016 Pin worm ova + Negative Negative 
18 H13906 Pin worm ova + Negative Negative 
19 G81309 Pin worm ova + Negative Negative 
20 H29993 Pin worm ova + Pin worm ova + Pin worm ova + 
21 G75288 Pin worm ova + Negative Negative 
22 D02683 Pin worm ova + Negative Negative 
23 G76842 Pin worm ova + Pin worm ova + Pin worm ova + 
24 H28017 Pin worm ova + Negative Negative 
25 H02315 Pin worm ova + Pin worm ova + Pin worm ova + 
26 G80270 Pin worm ova + Negative Negative 
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27 H17908 Pin worm ova + Negative Negative 
28 G24110 Pin worm ova + Negative Negative 
29 G76580 Pin worm ova + Pin worm ova + Pin worm ova + 
30 H32426 Pin worm ova + Negative Negative 
31 H09430 Pin worm ova + Negative Negative 
32 H20683 Pin worm ova + Negative Negative 
33 G50754 Pin worm ova + Negative Negative 
34 G76580 Pin worm ova + Pin worm ova + Pin worm ova + 
35 H17446 Pin worm ova + Negative Negative 
36 H62705 Pin worm ova + Negative Negative 
37 H21122 Pin worm ova + Pin worm ova + Negative 
38 G82344 Pin worm ova + Pin worm ova + Pin worm ova + 
39 H39484 Pin worm ova + Pin worm ova + Pin worm ova + 
40 H44725 Pin worm ova + Pin worm ova + Pin worm ova + 
  
16.Statistical analysis  
All collected data were entered into MS Excel software using different columns as 
variables and rows as patients. STATA software was used to perform statistical analysis. 
Basic descriptive statistics include frequency distributions and cross- tabulations were 
performed. Bar diagram, Pie charts were used to describe the value of different variables 
for pictorial representation. The quantity variables were expressed as Mean and standard 
deviation and qualitative data as percentage. A probability value of less than 0.05 was 
determining the significance between before and after treatment.  
Clinical Symptoms score before and after treatment 
Treatment Mean ± Std Dev 95% of C.I Significance (t, p) 
Before (40) 4.725 ± 0.98 4.4 to 5.04 32.75 
P <0.0001 After (40) 0.75± 0.8 .49 to 1.00 
The mean and standard of clinical symptoms score of Keerinoi, before and after treatment 
were 4.725± 0.98 and 0.75 ± 0.8 respectively which is statistically highly significant (t-
vale-32.75,P<0.0001).The reduction of clinical symptom score from the start of the 
treatment is 84% at the end of the treatment.  
                                               
 
 
 
    Discussion 
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                                               6.DISCUSSION   
           Keeri noi is one of the most common illness in children which remains as the 
common aetiological factor for anaemia, malnutrition. Keeri noi is caused mainly due to 
food and water contamination, improperly cooked food unhygienic sanitary habits. It is 
widespread among school children. The symptoms of Keeri Noi are found to be varying 
according to the siddha literature. On compiling the evidences, the Keeri Noi may be 
correlated with mixed worm infestation. The present study is mainly focused to find the 
efficacy of  Elisevi kudineer in treating Pinworm. Eventhough there are many health care 
programmes to control the Worm infestation especially in children, the goal of 
achievement is yet to attain in end user level.  
              The drugs which are mentioned in Siddha literature for the management of 
Keerinoi were selected and the study is conducted after the proposal was screened by the 
Screening committee of National Institute of Siddha and the trial was also approved by the 
Institutional Ethical Committee (IEC) approval no:NIS/IEC/8-14/23-26-08-2014. The 
trial was registered in Clinical trial registry of India registration no: 
CTRI/2016/05/006934.   
            Physico-chemical analysis was done as preliminary evaluation on Elisevi kudineer. 
The method of measuring the moisture content in solid or semi-solid materials is loss on 
drying (LOD). Low moisture content is always desirable for higher stability of drugs.In 
Elisevi kudineer, the loss on drying at 1050C was found to be 8.69%, it falls in between 
the limit range (1-20%). So the determination of moisture content shows the good stability 
of the drug Elisevi kudineer. 
          The ash values represent the purity of the drugs. The total ash includes  
non-physiological
ash, which is the residue of the extraneous matters like sand/soil, inorganic materials. The 
non-physiological ash is represented by acid insoluble ash. The total ash in Elisevi 
kudineer found to be 4.79%, and the acid insoluble ash to be 0.53%. The both ash value 
were under limits. Theminimal level of acid insoluble ash shows the less inorganic residue 
and purity of the drug Elisevi kudineer. 
           The extractive values helps to indicate the nature of chemical constituents present 
in  the drug. The water soluble substance is polar in nature and the alcohol has the ability 
to dissolve non-polar substance. The water soluble extract value of Elisevi kudineer is 
28.85% and the Alcohol soluble extractive is 20.45%, it shows the possibility of water 
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soluble constituents such as tannins, resins and alkaloids to be present in the drug. The 
drug will show good absorption.  
         Qualitative chemical analysis of the trial drug revealed the presence of starch, 
tannins, Chloride, phosphate, iron and alkaloids. Presence of iron increases the Hb level.  
           The patients were recruited for the trial based on inclusion and exclusion criteria 
and after getting the consent from the patient. 40 patients were included in this study. The 
40 patients were treated in OPD of Ayothidoss Pandithar Hospital of National Institute of 
Siddha. Separate proforma was maintained for every patient. Progress chart was also 
maintained to monitor the clinical signs and symptoms of the disease.  
The treatment was aimed at normalizing the deranged thodams and providing relief 
from symptoms. 
 The patients were treated with trial drug Elisevi kudineer for 3 days. Patients were 
instructed to take the medicines regularly and advised to follow pathiyam.  
After completion of the study, the patients were advised to visit the Out-Patient 
ward of Department of Kuzhanthai Maruthuvam for 1 month for follow-up. The results 
observed during the study period were discussed by the author below.   
           This study evaluates t Elisevi kudineer
Keeinoi. 
 
CLINICAL REVIEW 
 Sex  
            By the results of the clinical study, Female children (55%) were affected more than 
male children (45%). But there is no reference regarding the incidence of Keeri Noi to a 
particular sex according to Siddha literatures.  
 
Age  
            The age limit for the cases taken for study ranged from 8 to 12 years. Among the 
affected children (52.5%) were found to be with the age of 8years,( 5%) were found to be 
with the age of 9 years, (15% )were found to be with the age of 10 years and (20%) were 
found to be with the age of 11 years , (7.5%) were found with the age of 12 years.  
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Socio-economic status 
           About (25%) patients were under lower income group, (45%) patients were under 
middle income group and (30%) patients were under high income group.  The highest 
incidence occurred in middle income group and also affects lower and upper income 
group.     
 
Duration of illness 
           From the results, the duration of illness of the participants were more within 6 
months of duration about (72.5%). 
 
Kaalam  
          Most of cases, subjected to this study reported predominantly in Munpani (47.5%) 
and Pinpani Kaalam (40%) less in Elavenil (12.5%). 
 
Thinai  
         Among 40 cases, (77.5%) were from Neithal Nilam, (22.5) were from Marutham 
Nilam according to the literatures.  
 
Food habits 
        According to food habits (75% ) cases had mixed diet, and  (25%) vegetarian diet. 
The highest incidence of cases was observed in mixed diet of food habits.  
 
Habitual disorder 
        For all 40 cases recruited, (47.5%) of the case reported for having the habit of Bed 
wetting, (37.5%) with the habit of Nail bitting, (17.5%) with habit of Pica, and (5%) have 
the habit of Thumb sucking. Thus the result concludes that the higher incidence of habitual 
nail bitting cause this disease which further leads to bed wetting. 
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Mukkutram   
 
Vali (Vatham) 
      Due to the derangement of different vatha the following symptoms occur. Abanan was 
affected in (100%) cases and causes constipation, Itching around the anal and Passage of 
worms. Samanan was affected in (100%) cases and fails to neutralize the other 
vayus.Uthanan was affected in (27.5%) of cases and causes Teeth grinding during sleep, 
Viyanan was affected in (57.5%) of cases and causes Pain around the umbilicus and 
Kirukaran was affected in (67.5%) and causes Loss of appetite. 
 
Azhal (Pitham) 
       Due to the derangement of Pitham the following symptoms occur. Analapitham         
was affected (70%) and causes poor appetite. Ranjakam was affected (30%) and causes 
Pallor of skin. Prasagam was affected (27.5%) and causes pallor of skin. 
 
Iyyam (Kabam) 
       Deranged Avalambagam was affected (100%) .Klethagam was affected (70%) and 
causes loss of appetite. 
Udal Kattukal  
      In this study, Saaram and Senneer were affected in (100%) of the cases and (30%) 
respectively.  
 
Envagai Thervukal  
         Naa, Niram, Vizhi, were affected in (12%), (12%) (12%) of cases respectively and 
Malam was affected in (100%) of cases. The diagnosis was made on the basis of Envagai 
Thervukal and available modern investigation methods. 
Neikuri  
        In the present study, (27.5 %) of patient had vatha neikuri, (55%) was observed as 
pitha neikuri and (17.5%) was observed as kaba neikuri. 
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Clinical Features 
         The clinical features recorded as Peri anal itching(100%), Pain around the umbilicus 
(90%), Loss of appetite (77.5%), Teeth grinding during sleep (67.5%), Bed 
wetting(47.5%),Passage of worms in stools(90%) before treatment . The symptoms 
showed a good prognosis after treatment with reduced percentage of clinical features as 
(10%) (0 %) , (35%), (2.5%), (27.5%),( 0%) respectively.  
              The reduction of clinical symptom score from the start of the treatment is 84% at 
the end of the treatment.  
 
Lab Investigation:  
          Routine motion examination were done before the treatment. Scotch tape test for 
Ova and cyst was done at I and II interval shows (70%) and (72.5%) of results with 
absence of ova and cyst. 
Drug review 
         The pharmacological studies already reported on the individual drugs also favour its 
effect in disease Pinworm as given below: 
Elisevi have a potent Antianthelmintic activity and Antioxidant activity. 
Vaividangam have mainly an Antianthelmintic activity. 
Murungaipattai have Antianthelmintic activity . 
Kadukai. Nellikai,Thandrikai have Antianthelmintic activity and Antioxidant 
activity. 
 
Treatment  
           In this study all 40 cases were treated with Elisevi kudineer. The study shows that 
the trial drug have the property to neutralise the deranged vital humours and expels the 
Keeri Poochi in children. The clinical symptoms of the children show a bigger variance 
before and after treatment. The Scotch tape test by the first interval shows only (70 %) of 
absence of ova and cyst .It should also be noted that by the Scotch tape test at II interval 
shows that (72.5%) of absence of ova and cyst after treatment.  
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Statistical analysis 
         The datas from the clinical study are analysed statistically and found that the results 
were significant and the drug showed a good results. The clinical symptom score of 
Elisevi kudineer, before and after treatment were  4.725± 0.98 and 0.75 ± 0.8  respectively 
which is statistically significant. (t-vale-32.75,P<0.0001). 
 
            No adverse effect reported clinically throughout the study period.  
         The prior studies on the individual drugs for the anthelmintic activity also favours 
the effect of the trial drug to this disease Keeri Noi.  
          However the study was primarily limited by its small sample size. An earlier start in 
data collection would have increased the time needed to survey more recruitments. Ideally 
the participants of the study represented a narrow range of locality, ethnicity and age. A 
larger sample with more diversity would have benefit the study on exploring the identity 
of Keeri Noi 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                
   
 
 
 
      Summary 
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                                         7.SUMMARY  
       Patients attending the OPD of NIS having  the  compliants of Keerinoi diagnosed    
clinically   and    the   patients    were    observed    for     clinical    diagnosis. Clinical   
symptoms    of   Keerinoi emphasis  with the symptoms of Thread worm like  Itching 
around the anal region, pain around the umbilicus, loss of appetite, bed wetting,  Teeth 
grinding during sleep, Passage of worms in stools. 
        Clinical   diagnosis of Keerinoi was   done  on  the   basis  of  the clinical features   
described  in  Balavagadam  text.  
          Clinical studies were carried out after obtaining getting approval  from IEC of 
Institute of Siddha and the trial was registered in Clinical trial registry of India. The 
medicines were prepared after obtaining proper authentication from Medicinal Botany 
Department. Chemical analysis, physicochemical analysis ,Pharmacological activity (Anti 
anthelmintic ) for the drugs was performed.  
          The patients with Keerinoi were recruited based on Inclusion and Exclusion criteria 
and a detailed study was done. Separate proforma was maintained for each patient along 
with daily progress chart to monitor the prognosis.            
             The chemical analysis of drugs shows the presence of Chloride, Phosphate, Iron, 
Starch, Tannins,and alkaloids.  
              The physicochemical analysis showed the trial drug is in appropriate consistency 
for trial study. The patients have not complained of any adverse effects or difficult ies 
during the course of treatment. Thus the drug is found to be safe and effective in the 
management of Keerinoi.  
         The  clinical efficacy  of  the  drug  was  analyzed  statistically  on  all  the  symptoms 
mentioned in  the  assessment  criteria.  
        The observation made during the clinical study showed that the trail drug Elisevi 
kudineer was clinically effective on Keerinoi 
 
 
 
 
 
 
 
 
 
 
 
 
     Conclusion 
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                                                 8.CONCLUSION  
              
               The Siddha system of medicines has certainity with safer medications to treat 
children. In the present study, the trial drug Elisevi kudineer is treated to the children of 
age group, 8  12 years who are all diagnosed to have Keeri Noi  
              The ingredients of Elisevi kudineer are feasible and useful; These compounds 
may serve as potentially useful drug at a lower cost.  
                The medicine has many properties to control the signs and symptoms of Keeri 
Noi.  
               During the course of treatment, no adverse interactions were observed.  
               Clinical improvement has been noted and analysed statistically which implies the 
trial drug has very significant result  84% and the lab investigation shows 72.5% cases 
with good results. 
               The present clinical study has established that Elisevi kudineer is having good 
result in reducing the majority of symptoms of the Keeri noi and in expeling Keeri Poochi. 
               Further studies are required to establish its mechanism of action. By encouraging  
result of above study the drug may be taken for larger study in treatment of Keeri Noi. 
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                                         9.ANNEXURE  
                        NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI  600047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CHILDREN-  
                                                AN OPEN  CLINICAL STUDY 
  
                                                  FORM-1  SCREENING FORM 
1.  Scr. No:    2. OP No:                           3.Name:          
4. Age:    5.Sex:          6.Date of Screening:   
7.  Date of completion: 8.Informant:         9.Reliablity:   
 
INCLUSION CRETERIA:      YES                                 NO  
1. Age: between 8-12 years 
2. Having complaints of Loss of appetite 
3. Presence of peri anal itching   
4. Pain around the umbilicus       
5. Teeth grinding during sleep  
6. Bed wetting 
7. History of passing worms in the stools 
8. Positive investigation of ova and cyst of worms 
EXCLUSION CRITERIA:  
     1.Amebiasis. 
                 2.Patient infested with round worm 
                 3.Patient infested with hook worm. 
     4.Negative investigation of ova and cyst of worms. 
ADMITTED TO TRIAL:  YES              NO              IF YES, SERIAL NO:  
Signature of the Investigator:  
Signature of the Lecturer: 
Signature of the HOD:   
Date &Station: 
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                         NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI  600047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
I IN 
CHILDREN - AN OPEN CLINICAL STUDY. 
  
FORM-2- CONSENT FORM 
CERTIFICATE BY INVESTIGATOR 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the parent/guardian 
Signature  _________________ 
Date   _________________  
Name  _________________ 
CONSENT BY PARENT 
 I have been informed to my satisfaction, by the attending physician, the purpose of 
the clinical trial, and the nature of drug treatment and follow-up including the laboratory 
functions. 
 I am aware of my right to opt my son/daughter out of the trail at any time during 
the course of the trail without having to give the reasons for doing so.  
 I, exercising my free power of choice, here by give my consent to include my 
son/daughter as a subject in the clinical trial of a Siddha Drug, 
 
      Signature  __________________ 
Place:      Name   __________________ 
Date :      Signature of witness  __________________ 
      Name   __________________ 
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NATIONAL INSTITUTE OF SIDDHA 
  AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI  600047. 
  DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
                
KEERINOI IN   CHILDREN-  AN OPEN CLINICAL STUDY. 
 
FORM- 3-  CASE REPORT FORM 
 
1.HISTORY TAKING                                  Demographic data 
 
OP/IP No. Visit Date : (__/__/____) 
Name  
Age  
Gender             Male             Female 
Father/ Mother /Guardian Name : 
 
 
Fathers/Mother Occupation : 
 
 
 Monthly  Income 
 
 
Religion  
 
Hindu                 Christian    
Muslim               Others       
Socioeconomic Status  
 
 
 Informant  
 
 
Postal Address 
Contact No : 
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1.Complaints and Duration 
 
 
 2.Present illness 
 
 
3.History of Past Illness  
 
History /Symptoms/Signs  Yes  No  If, Yes Details 
Any Similar Complaints  
Hospitalization 
Any other        _____________ 
 
Family History 
Any Hereditary/ Familial Disease             Yes                      No 
If Yes, Details-------- 
 
Immunisation History  
Immunization   complete        Incomplete         Complete but time lag 
 
Food habits: 
1. Veg        2. Non-Veg  3. Mixed 
 
General assessment     YES       NO 
1. Pica                               
2. Nail biting 
3. Thumb sucking 
 
General Examination              YES                       NO 
1. Pallor    
2. Jaundice      
3. Cyanosis      
4. Clubbing      
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5. Pedal oedema      
6. Lymph adenopathy     
 
Vital signs:- 
1. Pulse rate / mint 
2. Heart rate / mint 
3. Respiratory Rate / mint 
4. Temperature 
 
Anthropometry:- 
          Height 
          Weight 
 
 SYSTEMIC EXAMINATION:                  
Gastro intestinal system 
a)  INSPECTION: 
    
Shape                                                        Normal                 Abnormal      
 
Symmetry                                                 Normal                 Abnormal    
 
Abdominal Distension :                            Present                 Absent 
 
 Prominent veins:                                       Present                  Absent    
 
 Hernia                  :                                    present                  Absent 
 
Visible peristalsis :                                    present                   Absent 
 
b)PALPATION: 
Tenderness                  Yes No 
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Organomegaly 
                                    Liver 
                                    Spleen 
                                    Kidney 
                                    Aorta  
                                    Bladder                 
c)PERCUSSION 
Percussion  of Abdomen  :              Normal                     
 
                                                      Hyper resonance                                                            
 
                     Dullness                                 
D)   Auscultation: 
Bowels sounds 
 Normal decreased increased 
Other systems:   Normal           Affected 
Cardio vascular system: 
            Respiratorysystem  
Musculo skeletal system:  
Central nervous system: 
Clinical assessment:           YES                    NO 
Peri anal itching    
 
Pain around the umbilicus 
 
Loss of appetite      
 
Teeth grinding during sleep 
 
Bed wetting     
             
History of Passing worms in the stools 
 
105 
 
SIDDHA ASSESSMENT  
Nilam:-  
Kurinji  Mullai  Marutham    Neithal Paalai 
 
 
Kaala Iyalbu:-  
 Kaarkalam  Koothirkaalam           Munpanikaalam 
 Pinpanikaalam I           Ilavenirkaalam           Muthuvenirkaalam 
 
Yaakai 
 Vatham  VathaPitham               VathaKabam 
 Pitham   Pithavatham   PithaKabam 
 Kabam   KabaVatham   KabaPitham 
 
Gunam  
 Sathuvam   Rasatham   Thamasam 
 
Pori / Pulangal 
               Normal Affected                Normal Affected     Remarks 
Mei   Unarvu 
Vaai        Suvai 
Kan                                                       Parvai 
Mooku                                                Natram 
Sevi                                                     Oli 
 
Kanmendhirium / Kanmavidayam 
  Normal        Affected           Normal            Affected     Remarks 
Kai                                                     Dhanam   
Kaal                  Ghamanam   
Vaai                                                   Vaku 
Eruvai                                                Visarkam 
Karuvai                                              Anantham 
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Uyir Thadhukkal 
Vatham:  Normal Affected  Remarks 
Pranan  
Abanan 
Viyanan  
Uthanan 
Samanan 
Nagan  
Koorman 
Kirukaran  
Devathathan   
Dhananjeyan    
Pitham:-  Normal Affected  Remarks 
Analam  
Ranjagam    
Saathagam   
Alosagam  
Prasagam 
Kabam:-  Normal Affected  Remarks 
Avalambagam    
Kilethagam   
Pothagam  
Tharpagam   
Santhigam  
Udal thathukkal 
   Normal Affected  Remarks 
Saaram 
Senneer  
Oon 
Kozhuppu 
Enbu 
Moolai 
Sukilam / Suronitham 
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EnvagaiThervugal 
Naa            Normal          Affected  Remarks 
            Niram 
 Thanmai 
 Suvai 
Niram   
Mozhi  
Vizhi  
 Niram 
 Thanmai 
 Parvai 
Sparisam  
Malam 
 Niram    
 Nurai    
 Elagal        Yes        No  
 Erugal         Yes                  No  
Moothiram  
Neerkuri:-                   Normal        Affected 
Niram    
 Edai   
 Nurai     
 Manam    
 Enjal   
Neikuri: 
Vatham  
 Pitham                                                                                                                                                                                                                                                          
 Kabam 
           Others  
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Naadi: 
ThaniNadi 
 Vadham          Pitham          Kabam 
ThonthaNadi 
            Vathapitham          Pitha vatham        Pitha kabam Kabapitham 
ThodaNadi 
 Vatha kabam          Kaba vatham 
Mukkutra Nadi 
 
Diagnosis: 
 
 
 
Treatment: 
 
 
DRUGS ISSUED:_____________ 
 
Date  : ___________________     
Station : ___________________  
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                         NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI  600047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
CHILDREN-  
                                          AN OPEN  CLINICAL STUDY 
 
                                                   4.CLINICAL ASSESSMENT FORM 
  
S.NO CLINICAL SYMPTOMS 1s day 7th day 
1. Presence of peri anal itching.   
2. Pain around the umbilicus   
3. Loss of appetite   
4. Teeth grinding during sleep.   
5. Bed wetting.   
6. History of passing worms in the stools   
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                  NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI  600047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CHILDREN-  
                                                      AN OPEN  CLINICAL STUDY 
 
                                     5.LABORATORY INVESTIGATIONS  
 
 
 
Signature of  Investigator 
Date:  
 
Station: 
 
                           
 
 
 
 
 
 
Special Investigation 
Before treatment  
Date: 
After treatment    
Date: 
Scotch tape test   
Stools Investigation 
  
Ova   
Cyst   
Occult blood   
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FORM 6  PATIENT INFORMATION SHEET 
 
Name of Principal Investigator:  
Name of the institute: National Institute of Siddha, 
            Tambaram Sanatorium, 
               Chennai-47. 
 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL. 
               I, ________________________________________Studying as PG Student in 
Dept. of Kuzhandhai maruthuvam at National Institute of  Siddha, Tambaram Sanatorium 
ENTEROBIUS VERMICULARIS). Threadworm 
is a most common disease in children. In this regard, I am in a need to ask you few 
questions. I will maintain confidentiality of your comments and data obtained. There will 
be no risk of disclosing your identity and no physical, psychological or professional risk is 
involved by taking part in this study. Taking part in this study is voluntary. No 
compensation will be paid to you for taking part in this study. 
           You can choose not to take part. You can choose not to answer a specific question. 
There is no specific benefit for you if you take part in the study. However, taking part in 
the study may be of benefit to the community, as it may help us to understand the problem 
of defaulters and potential solutions. 
             If you agree your child to be a participant in this study, he/she will be included in 
the study primarily by signing the consent form and then you will be given the internal 
medicine ELISEVI KUDINEER  10ml with 1gm vaaividangam(8-10 years),  20ml with 
2gm vaaividangam(10-12years) Bid.  
            The information I am collecting in this study will remain between you and the 
principal investigator (myself). I will ask you few questions through a questionnaire.  
The questionnaire will take approximately 20 minutes of your time. 
If you wish to find out more about this study before taking part, you can ask me all 
the questions. You may contact myself, Dr.L.ELAMATHI, PG Student cum principal 
investigator(7200801587) of this study National Institute of Siddha,Chennai-47. You can 
also contact the Member-secretary of Ethics committee, National Institute Siddha,Chennai 
600047, Tel no : 91-44-22380789, for rights and participation in the study. 
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                    NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI  600047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CHILDREN-  
  AN OPEN CLINICAL STUDY. 
 
  
1.  S.I. No:    2. OP/ IP No:                           3.Name:                                                  
4.  Age:       5.Gender:   6.Date of Enrollment:   
7.  Date of completion: 8.Informant:   9.Reliablity:   
FORM-7 WITHDRAWAL  
Date of trial commencement    : 
Date of withdrawal from trial   : 
Reason(s) for withdrawal   : Yes/ No  
Long absence at reporting   : Yes/ No 
Irregular treatment     : Yes/ No 
Shift of locality      : Yes/ No 
Complication adverse reactions if any : Yes/ No 
Exacerbation of symptoms   : Yes/ No 
 Patient not willing to continue  : Yes/ No 
 
Date:       Signature of Principal Investigator 
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                     NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI  600047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
I IN 
CHILDREN - AN OPEN CLINICAL STUDY. 
   
FORM-8- ADVERSE REACTION 
1.  Sl.No:    2. OP/ IP No:                           3.Name:                                                   
4.  Age:      5.Gender:   6.Date of Enrollment:  
7.  Date of completion: 8.Informant:   9.Reliablity:   
   
Name       : 
Age       : 
Gender    : 
OPD/ IPD No    : 
Registration No    : 
Date of trial commencement  : 
Date of withdrawal from trial   : 
Description of adverse reaction  : 
 
 
Date:       Signature of Principal Investigator 
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                    NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI  600047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
       
KEERINOI IN CHILDREN - AN OPEN CLINICAL STUDY 
 
  
 
  ASSENT FORM  
 
I,      understand that my parents (mom and dad)/guardian 
 
 .      
I am taking part because I want to.  I have been told that I can stop at any time I 
want to and nothing will happen to me if I want to stop. 
       
                                                             
 
 
 
                                                                   Signature 
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1. Patient / consumer identification (please complete or tick boxes below as 
appropriate) 
NATIONAL PHARMACOVIGILANCE PROGRAMME FOR SIDDHA 
DRUGS 
 
 
Please note:  i. all consumers / patients and reporters information will remain 
confidential. 
ii. It is requested to report all suspected reactions to the concerned, even if  
it does not have complete data, as soon as possible. 
Peripheral Center code:     State:  
  
2. Description of the suspected Adverse Reactions (please complete boxes 
below) 
  
Date and time  of 
initial observation 
 Season: 
Description of 
reaction   
 
 Geographical area: 
 
 
Name  Father name 
 
Patient / Record No. 
Ethnicity  Occupation 
Address  
Village / Town 
Post / Via 
District / State    
Date of Birth / Age: 
 
Sex:     Male / Female  
Weight : 
Degam: 
Reporting Form for Suspected Adverse Reactions to Siddha Drugs 
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3. List of all medicines / Formulations including drugs of other systems 
used by the patient during the reporting period: 
 
Medicine Dail
y 
dose 
Route of 
administration 
& Vehicle  
Adjuvant 
Date  Diagnosis for 
which medicine 
taken  
Starting Stopped 
Siddha 
 
 
 
 
     
Any other system 
of medicines 
 
 
     
                                                                                                                                    
4. Brief details of the Siddha Medicine which seems to be toxic : 
 
Details Drug  1 Drug  2 Drug  3 
a) Name of the medicine    
b) Manufacturing unit and 
batch No. and date 
   
c) Expiry date    
d) Purchased and obtained 
from 
   
e) Composition of the 
formulation / Part of the drug 
used 
   
 
b) Dietary Restrictions if any 
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c) Whether the drug is consumed under Institutionally qualified medical supervision or 
used as self medication.  
d) Any other relevant information. 
 
5. Treatment provided for adverse reaction: 
 
6. The result ofthe adverse reaction / side effect / untoward effects (please 
complete the boxes below) 
 
Recovered:           Not 
recovered: 
 Unknown: Fatal: If Fatal 
Date of death: 
Severe:   Yes   /   No. Reaction abated after drug stopped or dose reduced: 
 
Reaction reappeared after re introduction: 
 
 
Was the patient admitted to hospital? If 
yes, give name and address of hospital 
 
 
7. Any laboratory investigations done to evaluate other possibilities? If 
Yes specify:  
 
8. Whether the patient is suffering with any chronic disorders? 
Hepatic    Renal    Cardiac    Diabetes    Malnutrition  
 
Any Others 
 
9. H/O previous allergies / Drug reactions: 
 
10. Other illness (please describe): 
11. Identification of the reporter: 
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Type (please tick):  Nurse / Doctor / Pharmacist / Health worker / Patient / Attendant / 
Manufacturer /                                                                      
                                Distributor / Supplier / Any others (please specify) 
Name: 
 
Address: 
 
Telephone / E  mail if any : 
 
 
 
Signature of the reporter:       Date: 
 
 
Please send the completed form to:  
            The Director 
            National Institute of Siddha, 
(Pharmacovigilance Regional         Centre For Siddha Medicine), 
                                                         Tambaram Sanatorium, Chennai-600 047. 
 (O) 044-22381314           Fax : 044  22381314 
         Website :www.nischennai.org 
         Email: nischennaisiddha@yahoo.co.in 
 
 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ** * * * *  
 
 
 
 
 
 
Name & address of the 
RRC-ASU/ PPC-ASU 
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This filled-in ADR report may be sent within one month of observation /occurrence 
of ADR   
 
 
 
Date:                                                                              
Station:  
 
Date :      
 
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                   Signature of the HOD    
 
 
 
 
 
 
Who Can Report?     
 Any Health care professionals like Siddha Doctors /  Nurses / 
Siddha Pharmacists / Patients etc.  
What to Report?  
 All reactions,  Drug interactions,  
Confidentiality  
 
protected to the fullest extent 
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